Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Excerpt | Reference |
|---|
| "Tuberculosis is much commoner among immigrants to Britain than among the native-born." | ( , 1978) |
| "Drug treatment of tuberculosis is reviewed." | ( Koerner, SK; Pinsker, KL, 1976) |
| "Multidrug-resistant tuberculosis is readily transmitted among hospitalized patients with AIDS." | ( Castro, KG; Crawford, JT; Dooley, SW; Edlin, BR; Grieco, MH; Kilburn, JO; Ong, KR; Sordillo, EM; Tokars, JI; Williams, J, 1992) |
| "tuberculosis is highly immunoreactive and should be evaluated for its capacity to elicit protective immunity." | ( Barnes, PF; Bloom, BR; Brennan, PJ; Fong, SJ; Houghten, RA; Mehra, V; Minden, P; Modlin, RL; Rivoire, B; Voegtline, MS, 1992) |
| "tuberculosis are reported." | ( Grosset, J; Ji, B; Truffot-Pernot, C, 1991) |
| "Tuberculosis is a major public health problem in developing countries." | ( Broekmans, JF, 1991) |
| "tuberculosis are detected by human antibodies in Western blots and ELISA." | ( Jansen, HM; Kolk, AH; Kuijper, S; Speelman, P; Verbon, A, 1990) |
| "Tuberculosis is one of the most widespread infections known in the world." | ( Kochi, A, 1991) |
| "tuberculosis is becoming more frequent, and that blood cultures may be helpful in establishing or confirming a diagnosis of tuberculosis in patients with HIV-1 infection." | ( Barber, TW; Craven, DE; McCabe, WR, 1990) |
| "Tuberculosis is on the increase in the United States, so physicians would be prudent to renew familiarity with the disease." | ( Dickensheets, DL, 1989) |
| "Although tuberculosis is a recognised cause of adrenal insufficiency, little is known about adrenal function in patients with active tuberculosis." | ( Barnes, DJ; Naraqi, S; Temu, P; Turtle, JR, 1989) |
| "Though tuberculosis is principally a disease of the male population, it is more prevalent among females of the lower age group." | ( Hazra, J, 1986) |
| "Tuberculosis is a significant public health problem in developing countries, despite the fact that the means for effective control have been available for more than 35 yr." | ( Pedraza, RO; Pérez-Stable, EJ, 1984) |
| "in countries where tuberculosis is still rampant, but which are economically underdeveloped." | ( Aquinas, M, 1982) |
| "Tuberculosis is one of the most common infections in Zambian adults and children infected with HIV." | ( Bhat, G; Chintu, C; DuPont, H; Luo, C; Raviglione, M; Zumla, A, 1993) |
| "Tuberculosis is characterized by fever, weight loss, a prolonged acute-phase protein response and granuloma formation." | ( Friedland, JS; Griffin, GE; Hartley, CG; Hartley, JC; Shattock, RJ, 1995) |
| "paratuberculosis is the agent of Johne's disease in ruminants." | ( Barletta, RG; Bermudez, LE; Foley-Thomas, EM; Whipple, DL, 1995) |
| "Ocular tuberculosis is currently rare in developed countries." | ( Boucheron, S; Gain, P; Gravelet, C; Maugery, J; Mosnier, JF; Sannace, C, 1994) |
| "tuberculosis is mediated by a site within CR3, which is distinct from the C3bi binding site." | ( Haidl, ID; Jefferies, WA; Speert, DP; Stokes, RW, 1993) |
| "tuberculosis are not usually active against MAC organisms, and the converse may also be true." | ( Young, LS, 1993) |
| "Tuberculosis is most likely to become active during the first three years following first infection for an healthy subject." | ( Nicod, LP, 1993) |
| "Tuberculosis is an important infection encountered after renal transplantation in third-world countries." | ( Chugh, KS; Jha, V; Joshi, K; Sakhuja, V; Varma, PP, 1996) |
| "Nasal tuberculosis is a rare entity since it early diagnosis and the improvements in treatment." | ( Echeverría Zabalza, ME; Grijalba Uche, M; Medina Solá, JJ, 1996) |
| "Tuberculosis is increasing in Siberia." | ( Besse, C; Connolly, M; Drobniewski, F; Ignatenko, N; Lyagoshina, T; Nye, P; Paul, J; Tayler, E, 1996) |
| "tuberculosis are performed." | ( Arain, TM; Hickey, MJ; Humble, DJ; Langhorne, MH; Morgenroth, JN; Shawar, RM; Stover, CK, 1996) |
| "The prophylaxis of tuberculosis is cost-effective in that it prevents hospitalizations and eliminates the need for multidrug treatment of active disease." | ( Fisher, MA; Krance, MB, 1996) |
| "Tuberculosis is still a major health concern in the Federal Islamic Republic of the Comoros." | ( Aboubacar, O; Feyaerts, P; Josse, R; Molines, C; Thaoubani, D, 1996) |
| "Mycobacterium tuberculosis is the single, most important cause of morbidity attributable to a single infectious organism." | ( Harris, DP; Vordermeier, HM; Zhu, X, 1997) |
| "CNS tuberculosis is frequently observed in Indian AIDS cases compared with reports from industrialized countries where its occurrence is uncommon." | ( Jain, PP; Lanjewar, DN; Shetty, CR, 1998) |
| "Tuberculosis is one of the major public health problems that WHO has tackled throughout the last 50 years." | ( Maher, D; Nunn, P, 1998) |
| "Tuberculosis is a common infection of renal transplant recipients in developing countries." | ( Ark, E; Beşişik, F; Ecder, T; Ece, T; Kiliçarslan, I; Sever, MS; Tabak, L; Türkmen, A; Yildiz, A, 1998) |
| "Pharyngeal tuberculosis is an uncommon condition." | ( Kharoubi, S, 1998) |
| "Tuberculosis is a serious opportunistic infection in transplant recipients." | ( Paterson, DL; Singh, N, 1998) |
| "Tuberculosis is an endemic disease in our countries." | ( Bao, O; Diouf, B; Diouf, ML; Ka, MM; Mbengue, M; Moreira-Diop, T; Niang, A; Pouye, A, 1998) |
| "tuberculosis are about the same." | ( Duan, L; Li, H; Liang, G, 1997) |
| "tuberculosis are presented." | ( Bishai, W; Boyce-Jacino, MT; Goelet, P; Head, SR; Parikh, K; Rogers, YH, 1999) |
| "tuberculosis are treated with antibiotics (isoniazid and pyrazinamide), resulting in no detectable bacilli by organ culture." | ( Chan, J; Flynn, JL; Joseph, H; Mohan, VP; Scanga, CA; Yu, K, 1999) |
| "Tuberculosis is an important cause of morbidity and mortality in renal transplant recipients, but there are insufficient data regarding the efficacy and complications of therapy and of INH prophylaxis." | ( Duman, S; Ece, T; Kiliçaslan, Z; Ozkahya, M; Sayiner, A; Tokat, Y; Yildiz, A, 1999) |
| "Tuberculosis is common in drug users, although compliance with therapy may be difficult in this population." | ( Durante, AJ; Friedman, L; Henry, S; O'Connor, PG; Selwyn, PA; Shi, JM, 1999) |
| "pneumoniae and M." | ( Archibald, LK; Dobbie, H; Jarvis, WR; Kazembe, P; McDonald, LC; Nwanyanwu, O; Reller, LB; Tokars, J, 2000) |
| "Tuberculosis is currently an enormous global health problem." | ( Ellner, JJ; Johnson, JL, 2000) |
| "Tuberculosis is an example of an infection with an intracellular bacterium in which sensitivity is determined mainly by the host response." | ( Domingues-Junior, M; Guerra, JL; Palermo-Neto, J; Pinheiro, SR, 2000) |
| "Tuberculosis is the commonest opportunistic infection in HIV-infected patients in developing countries including India." | ( Cherian, T; Verghese, VP, 2000) |
| "tuberculosis is not a reliable indicator of INH resistance." | ( Dankert, J; de Haas, PE; Kuijper, EJ; van der Ende, A; van Doorn, HR; van Soolingen, D; Welten, AG, 2001) |
| "Tuberculosis is one of the most common infectious diseases worldwide and is responsible for the largest number of deaths from a single infectious cause." | ( Emili, J; John, KR; Norman, GR; Schmuck, ML; Scott, F; Upshur, RE, 2001) |
| "Sinonasal tuberculosis is a rare disease; its association with osteomyelitis of surrounding bone and cervical lymphadenopathy has been reported rarely." | ( Jang, YJ; Jung, SW; Kim, SJ; Koo, TW; Park, SG, 2001) |
| "Multidrug-resistant tuberculosis is an increasing public health concern in many parts of the world, especially in low-income countries, where most cases occur." | ( Angeby, KA; Hoffner, SE; Klintz, L, 2002) |
| "Congenital tuberculosis is rare, and the clinical presentation of tuberculosis during pregnancy and infancy is often non-specific, making recognition difficult." | ( Smith, KC, 2002) |
| "The resurgence of tuberculosis is one of the most serious global public health challenges of the twenty-first century." | ( Gandy, M; Zumla, A, 2002) |
| "Tuberculosis is the commonest cause of morbidity and mortality." | ( Maartens, G, 2002) |
| "tuberculosis are severe." | ( Cole, ST; Pym, AS; Saint-Joanis, B, 2002) |
| "Mycobacterium tuberculosis is the most important infectious agent causing illness, disability, and death worldwide." | ( Ruck, N, 1997) |
| "Tuberculosis is a very common lesion in surgical specimen in our country." | ( Haque, A; Huq, MH; Sarker, CB; Talukder, MS, 2002) |
| "Congenital tuberculosis is an uncommon disease t hat requires early diagnosis for successful therapy and vigilant follow-up of potential exposures in the NICU." | ( Holt, D; Laartz, BW; Larkin, JA; Narvarte, HJ; Pomputius, WF, 2002) |
| "Tuberculosis is worldwide considered as a major health problem with high morbidity and mortality rates." | ( Chanteau, S; Marchal, G; Rabe, O; Rasolofo Razanamparany, V, 2001) |
| "Tuberculosis is highly prevalent in Madagascar and most people are infected during childhood." | ( Cauchoix, B; Chanteau, S; Clouzeau, J; Ramarokoto, H; Rasolofo Razanamparany, V; Rasolonavalona, T; Vololonirina, EJ, 2002) |
| "Tuberculosis is still one of the commonest problems in the urban slums." | ( Bhagyalaxmi, A; Jivarajani, P; Kadri, AM; Lala, MK; Patel, M; Patel, T, 2003) |
| "Tuberculosis is one of the leading preventable causes of death." | ( Cynamon, MH; Dubey, VS; Kolattukudy, PE; Sirakova, TD, 2003) |
| "tuberculosis is a complex process mediated by pre- and posttranscriptional mechanisms." | ( Friedland, JS; Wright, KM, 2003) |
| "In France, tuberculosis is endemic, particularly in the Paris area (Ile-de-France) and in the south (Provence Alpes côte d'Azur) where immigration is greater than in other countries in northern Europe." | ( Castillo, L; Dellamonica, P; Hofman, P; Hofman, V; Kermarec, A; Landraud, L; Mouroux, J; Selva, E; Sicard, D; Vénissac, N, 2003) |
| "Non-respiratory tuberculosis is of little importance in adults." | ( , 1955) |
| "Multidrug-resistant tuberculosis is an increasing health problem worldwide, especially in developing countries." | ( Arenas, F; Caviedes, L; Chumpitaz, R; Evans, CA; Gilman, RH; Mayta, H; Montenegro, SH; Ortiz, J; Ticona, E; Valencia, T; Williams, DL, 2003) |
| "Tuberculosis is a major problem in this rural community in south India, with a prevalence of 605/100,000 for culture-positive tuberculosis and 323/100,000 for smear-positive tuberculosis." | ( Devi, TS; Frieden, TR; Gopi, PG; Kolappan, C; Narayanan, PR; Radhakrishna, S; Sadacharam, K; Subramani, R, 2003) |
| "Chemotherapy for tuberculosis is indicated in case of disease as well as in latent tuberculosis infection." | ( Greinert, U; Zabel, P, 2003) |
| "Since tuberculosis is rarely limited to the resected area, at least six months' rest in bed under medical supervision is necessary to permit cure of residual disease." | ( DUGAN, DJ, 1952) |
| "Diabetes and tuberculosis are bad companions each other." | ( Kawamori, R, 2004) |
| "Tuberculosis is the commonest HIV-1-related disease and the most frequent cause of mortality in young women in endemic regions." | ( Adhikari, M; Coovadia, H; Khan, M; Moodley, J; Pillay, T, 2004) |
| "tuberculosis is 5-10 % and highest during the first two years after infection." | ( Haas, WH; Hauer, B; Hohlfeld, J; Kropp, R; Loddenkemper, R; Loytved, G; Magdorf, K; Rieder, HL; Sagebiel, D; Schaberg, T, 2004) |
| "Esophageal tuberculosis is a rare clinical entity even in adults." | ( Sathiyasekaran, M; Shivbalan, S, 2004) |
| "It is possible that tuberculosis is transmitted from patients to healthcare workers (HCWs)." | ( Chandy, GM; Gopinath, KG; Kirubakaran, H; Mathai, E; Shanmugam, A; Siddique, S, 2004) |
| "Diagnosis of tuberculosis is sometimes difficult because of the low specificity of diagnostic procedures especially in patients on end-stage renal disease (ESRD)." | ( Fujigaki, Y; Hishida, A; Matsushima, H; Ohtake, T; Yonemura, K, 2004) |
| "Tuberculosis is a major cause of childhood morbidity and mortality in high-burden settings, particularly in the third-world settings." | ( Marais, BJ, 2004) |
| "Diagnosis of tuberculosis is mainly based on clinical features, histopathology, demonstration of acid fast bacilli (AFB) and isolation of Mycobacterium tuberculosis from the clinical specimens." | ( Katoch, VM, 2004) |
| "tuberculosis are well described, immune mechanisms underlying the evolution of HIV and mycobacterial coinfection remain poorly characterized." | ( Chen, ZW, 2004) |
| "In areas where tuberculosis is endemic in free-ranging white-tailed deer, management practices to prevent access of wildlife to feed intended for livestock should be implemented." | ( Palmer, MV; Waters, WR; Whipple, DL, 2004) |
| "Human tuberculosis is a complex disease caused by bacterial populations that are located in discrete lesions (microenvironments) in a single host." | ( Barry, CE; Boshoff, HI, 2005) |
| "Tuberculosis is one of the world's most devastating diseases, with more than two million deaths and eight million new cases occurring annually." | ( Kusner, DJ, 2005) |
| "Tuberculosis is the commonest opportunistic disease in persons infected with human immunodeficiency virus (HIV)." | ( Acchammachary, A; Bhavsar, M; Date, A; Inamdar, V; Iyyer, R; Mehendale, S; Pereira, M; Ramesh, K; Risbud, A; Tripathy, S, 2005) |
| "Tuberculosis is a leading cause of morbidity and mortality worldwide." | ( Callister, SM; DeCoster, DJ; Schell, RF; Vena, RM, 2005) |
| "Tuberculosis is endemic to developing countries like India." | ( Mundayoor, S; Radhakrishnan, I; Sarojini, S; Soman, S, 2005) |
| "Tuberculosis is highly prevalent in cattle in Madagascar." | ( Chanteau, S; Ferdinand, S; Quirin, R; Rakotoaritahina, H; Ramarokoto, H; Rapaoliarijaona, A; Rasolofo Razanamparany, V; Rasolonavalona, T; Rastogi, N; Sola, C; Vololonirina, EJ, 2006) |
| "Tuberculosis is the most frequent coinfection in humans infected with HIV-1, but little is known about mechanisms that favors coinfection." | ( Arce-Mendoza, AY; Caballero-Olín, G; Rosas-Taraco, AG; Salinas-Carmona, MC, 2006) |
| "Tuberculosis is one of the microbial diseases having a long history of its occurrence and yet to be eradicated from the world." | ( Ashokraj, Y; Bade, SR; Kaur, K; Panchagnula, R; Parmar, J; Singh, I, 2006) |
| "Breast tuberculosis is rare." | ( Imbiki, Z; Rakoto-Ratsimba, HN; Rakototiana, AF; Ranaivozanany, A; Razafimahandry, HJ; Samison, LH, 2005) |
| "Non-pulmonary tuberculosis is found with different frequencies in different countries of the world." | ( Głowacka, M; Kurek, J; Sandelewski, A; Wyrobiec, G, 2006) |
| "Mycobacterium tuberculosis is one of the leading causes of death worldwide, and multidrug-resistant tuberculosis (MDR-TB) is associated with a high case fatality rate." | ( Canducci, F; Cirillo, DM; Migliori, GB; Miotto, P; Penati, V; Piana, F, 2006) |
| "The eradication of tuberculosis is the greatest public health challenge for this developing country." | ( Adhikari, CM; Kandpal, V; Tewari, A; Tiwari, N, 2006) |
| "Tuberculosis is curable, but community surveys documenting epidemiological impact of the WHO-recommended DOTS strategy on tuberculosis prevalence have not been published." | ( Frieden, T; Gopi, P; Narayanan, P; Radhakrishna, S; Sadacharam, K; Santha, T; Selvakumar, N; Subramani, R, 2007) |
| "Tuberculosis is characterized by a tight interplay between Mycobacterium tuberculosis (M." | ( Altare, F; Bon, H; Botanch, C; Duteyrat, JL; Emile, JF; Lay, G; Levillain, F; Poquet, Y; Puissegur, MP; Salek-Peyron, P, 2007) |
| "Mycobacterium tuberculosis is an important human pathogen that is routinely cultured in clinical and research laboratories." | ( Chewins, J; Hall, L; Otter, JA; Wengenack, NL, 2007) |
| "Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen." | ( Aldrich, CC; Barry, CE; Beck, BJ; Bennett, EM; Boshoff, HI; Celia, L; Somu, RV; Wilson, DJ, 2006) |
| "Tuberculosis is today amongst the worldwide health threats." | ( Janin, YL, 2007) |
| "The incidence of tuberculosis is high in chronic kidney disease (CKD) which needs a high index of suspicion, early diagnosis and management for gratifying outcome." | ( Krishna, RP; Kumar, S; Kumar, SB; Padmanabhan, S; Venkata, RK, 2007) |
| "tuberculosis is leading to a reappraisal of the possibility of treating tuberculosis (TB) by immunotherapy." | ( Hernàndez-Pando, R; Lowrie, DB; Rook, GA, 2007) |
| "Tuberculosis is a common complication and leading cause of death in HIV infection." | ( Cavalcante, SC; Chaisson, RE; Durovni, B; Efron, A; Golub, JE; King, BS; Moore, RD; Moulton, LH; Pacheco, AG; Saraceni, V, 2007) |
| "Tuberculosis is the most frequent co-infection in human immunodeficiency virus (HIV)-infected individuals, and which still presents diagnostic difficulties." | ( Bizzoni, F; Butera, O; Carrara, S; Casetti, R; Girardi, E; Goletti, D; Vincenti, D, 2007) |
| "Tuberculosis is a global problem especially in children, more so because of the difficulty in the diagnosis of the disease." | ( Dayal, R; Kulshreshtha, S; Mohan, G; Sharma, P; Singh, M, 2007) |
| "Tuberculosis is a public health problem worldwide." | ( Howell, JM; Mohammadi, A, 2009) |
| "Mycobacterium tuberculosis is a bacterial pathogen that can persist for decades in an infected patient without causing a disease." | ( Bakala N'goma, JC; Canaan, S; Carrière, F; Côtes, K; Dhouib, R; Douchet, I; Maurin, D, 2008) |
| "Tuberculosis is treated with a group of drugs that need to be used over a long period of time and isoniazid is the major drug in this group." | ( Aktoğu, S; Bozok Cetintaş, V; Erer, OF; Eroğlu, Z; Kosova, B; Ozdemir, I; Topçuoğlu, N, 2008) |
| "A hallmark of tuberculosis is the ability of the causative agent, Mycobacterium tuberculosis, to persist for decades despite a vigorous host immune response." | ( Pandey, AK; Sassetti, CM, 2008) |
| "Tuberculosis is a widely prevalent disease in India." | ( Ganesan, K; Ganesan, S, 2008) |
| "Tuberculosis is now the most frequent initial ADI in France; this is probably the result of the increasing proportion of migrants from sub-Saharan Africa." | ( Allavena, C; Bentata, M; Costagliola, D; Fischer, P; Grabar, S; Lanoy, E; Mahamat, A; Mary-Krause, M; Rabaud, C, 2008) |
| "tuberculosis are very slow to give results, and due to the emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis, there is an urgent demand for new, rapid and accurate DST methods, particularly in low-income countries." | ( Angeby, K; Hoffner, S; Martin, A; Palomino, JC; Panaiotov, S; Portaels, F, 2008) |
| "marinum and M." | ( Brown, EJ; Cox, JS; Koo, IC; Morisaki, JH; Raghavan, S; Wang, C, 2008) |
| "tuberculosis are 7 cutinase-like proteins (CLP), not previously characterized in terms of their immunogenicity or vaccine protective efficacy." | ( Britton, WJ; Feng, CG; Ribeiro, JM; Sher, A; Valenzuela, J; West, NP; Wozniak, TM, 2008) |
| "tuberculosis is associated with this group of patients." | ( Farnia, P; Ghorbani, F; Jamali, M; Najafizadeh, K; Shiehmorteza, M, 2008) |
| "tuberculosis is associated with anthracotic bronchitis." | ( Farnia, P; Ghorbani, F; Jamali, M; Najafizadeh, K; Shiehmorteza, M, 2008) |
| "Tuberculosis is a major cause of mortality among patients with HIV and poses a risk throughout the course of HIV disease, even after successful initiation of antiretroviral therapy (ART)." | ( Getahun, H; Havlir, DV; Nunn, P; Sanne, I, 2008) |
| "When active tuberculosis is identified, combination therapy with isoniazid, rifampin, pyrazinamide, and ethambutol should be promptly initiated for a two-month "intensive phase," and in most cases, followed by isoniazid and a rifamycin product for a four- to seven-month "continuation phase." | ( Inge, LD; Wilson, JW, 2008) |
| "Tuberculosis is known to be one of the major infectious diseases with a high incidence among drug addicts." | ( Aggarwal, N; Dhingra, VK; Lall, D; Vashist, RP, 2008) |
| "Mycobacterium tuberculosis is one of the worlds' most successful and sophisticated pathogens." | ( Lin, MY; Ottenhoff, TH, 2008) |
| "Tuberculosis is a major threat to the public health allover world." | ( Chandra, PS; Kumar, VA, 2008) |
| "A screening of tuberculosis is recommended before anti-TNF therapy, and includes previous history questioning, chest X ray, tuberculin skin test with 5 international units of tuberculin." | ( Ben m'rad, M; Gherissi, D; Mouthon, L; Salmon-Céron, D, 2009) |
| "Pancreatic tuberculosis is a rare entity." | ( Aduli, F; Atiq, M; Dang, S; Olden, KW; Saccente, M, 2009) |
| "Pancreatic tuberculosis is rare and is frequently confused with pancreatic cancer on clinical presentation as well as on imaging studies." | ( Aduli, F; Atiq, M; Dang, S; Olden, KW; Saccente, M, 2009) |
| "tuberculosis is hypothesized to be the de novo synthesis of NAD via activation of the kynurenine pathway." | ( Miller, CL, 2009) |
| "Tuberculosis is a growing international health concern." | ( Abdelaal, A; Badran, E; El Mashad, N; El-Ghaffar, HA; Fathy, A; Zaghloul, MH, 2009) |
| "Tuberculosis is a major cause of childhood morbidity and mortality in Nigeria." | ( Adewole, IF; Cadmus, SI; Godfroid, J; Jenkins, AO; Murphy, RL; Osinusi, K; Taiwo, BO, 2009) |
| "Tuberculosis is the most common opportunistic infection in HIV-infected patients as well as the leading cause of death." | ( Nagendran, G; Swaminathan, S, 2008) |
| "Tuberculosis is a particularly important condition in solid-organ transplant recipients because of the delay in treatment caused by the difficulties involved in its diagnosis and because of the pharmacological toxicity associated with this treatment." | ( Aguado, JM; Benito, N; Doblas, A; Fortún, J; Meije, Y; Muñoz, P; Torre-Cisneros, J, 2009) |
| "Tuberculosis is a massive public health problem on a global scale and the success of Mycobacterium tuberculosis is linked to its ability to persist within humans for long periods without causing any overt disease symptoms." | ( Minch, KJ; Rustad, TR; Sherman, DR; Sherrid, AM, 2009) |
| "tuberculosis is sensitive to TMP-SMX." | ( Forgacs, P; Hall, L; Roberts, GD; Silverman, ML; Wengenack, NL; Zimmerman, SK, 2009) |
| "Tuberculosis is a disease with a high case fatality of 4." | ( Pardeshi, G, 2009) |
| "In vivo tuberculosis is exposed to continually changing drug concentrations for which static minimum inhibitory concentration (MIC) testing may be a poor surrogate." | ( Budha, NR; Hurdle, JG; Lee, RB; Lee, RE; Meibohm, B, 2009) |
| "Drug-resistant tuberculosis is a major problem worldwide." | ( Akrim, M; Chaoui, I; El Mzibri, M; Elouad, R; Jordaan, AM; Kourout, M; Lahlou, O; Sabouni, R; Victor, TC, 2009) |
| "Tuberculosis is the most prevalent infectious disease in the world." | ( Connell, ND; Venketaraman, V, 2009) |
| "Mycobacterium tuberculosis is one of the most notorious killers worldwide." | ( Cheng, Y; Pieters, J, 2010) |
| "Tuberculosis is considered to be 100% curable if adequate drug regimen is followed, still in developing countries it is becoming leading cause of death." | ( Prasad, R, 2009) |
| "tuberculosis is delayed and emphasize the importance of early immunity." | ( Behar, SM; Desjardins, D; Divangahi, M; Nunes-Alves, C; Remold, HG, 2010) |
| "Reactivation of tuberculosis is rare in patients receiving chemotherapy for solid tumours, and poorly documented in patients receiving molecular targeted therapy." | ( Billemont, B; Coriat, R; Goldwasser, F; Loulergue, P; Mir, O; Ropert, S, 2011) |
| "Tuberculosis is an endemic disease in developing countries like India." | ( Gupta, DK; Mahapatra, AK; Ramdurg, SR; Sharma, BS; Suri, A, 2010) |
| "Calvarial tuberculosis is endemic in developing countries." | ( Gupta, DK; Mahapatra, AK; Ramdurg, SR; Sharma, BS; Suri, A, 2010) |
| "Global control of tuberculosis is hampered by slow, insensitive diagnostic methods, particularly for the detection of drug-resistant forms and in patients with human immunodeficiency virus infection." | ( Alland, D; Allen, J; Blakemore, R; Boehme, CC; Gotuzzo, E; Hillemann, D; Jones, M; Krapp, F; Milovic, A; Nabeta, P; Nicol, MP; O'Brien, SM; Perkins, MD; Persing, DH; Rodrigues, C; Ruesch-Gerdes, S; Rustomjee, R; Shenai, S; Tahirli, R, 2010) |
| "Tuberculosis is one of the most common infectious diseases in India." | ( Palimar, V; Rastogi, P, 2010) |
| "Tuberculosis is a serious global health threat for which new treatments are urgently needed." | ( Bedarida, G; Campbell, S; Jakubiec, W; Kumar, V; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS; Zhu, T, 2011) |
| "Treatment of MDR tuberculosis is difficult and has been based for twenty years on the use of fluoroquinolones and injectable antibiotics such as amikacin, kanamycin and capreomycin." | ( Robert, J; Veziris, N, 2010) |
| "Tuberculosis is a worldwide health problem, and multidrug-resistant (MDR) and extensively multidrug-resistant (XMDR) strains are rapidly emerging and threatening the control of this disease." | ( Castañeda-Delgado, J; Hernández Pando, R; León, DA; Rivas-Santiago, B; Rivas-Santiago, CE, 2011) |
| "Tuberculosis is associated with increased lung cancer risk in male smokers." | ( Albanes, D; Engels, EA; Shiels, MS; Virtamo, J, 2011) |
| "Tuberculosis is still a major global health problem." | ( Aşık, G; Aslan, MH; Ciftçi, IH, 2011) |
| "Tuberculosis is a major global health challenge and is far from being controlled." | ( Kumar, V; Naithani, R; Sandhu, SS; Sharma, AK, 2011) |
| "tuberculosis is growing steadily; however, data on the genetic variation of isolates of M." | ( Dymova, MA; Filipenko, ML; Khrapov, EA; Krutko, VS; Liashenko, OO; Poteiko, PI, 2011) |
| "Mycobacterium tuberculosis is an intracellular pathogen and it resides inside the macrophage, which is considered to be the most important component of the immune system." | ( Balaji, KN; Mukhopadhyay, S, 2011) |
| "Tuberculosis is highly prevalent amongst children in India." | ( Dahiwale, N; Rao, S; Rawat, AK; Singh, J, 2011) |
| "Mycobacterium tuberculosis is the causative agent of a pulmonary epidemic that is estimated to infect one-third of the world's population and that has an increased incidence of multidrug resistance." | ( Bifani, P; Camacho, L; Dartois, V; Foo, DG; Hervé, M; Siew, JY; Singhal, A; Tay, HC, 2011) |
| "Thus, Alr of M." | ( Awasthy, D; Bharath, S; Sharma, U; Subbulakshmi, V, 2012) |
| "Tuberculosis is a public health problem worldwide, and new easy to perform diagnostic methods with high accuracy are necessary for optimal control of the disease." | ( Alavi, M; Amin, M; Ekrami, A; Khosravi, A; Kiasat, A; Samarbaf-Zadeh, AR; Zargar, B, 2011) |
| "smegmatis." | ( He, F; Lian, Y; Mi, X; Xiang, M; Yi, S, 2012) |
| "Mycobacterium tuberculosis is known to induce apoptosis and it was shown that live but not heat killed M." | ( Belisle, JT; Brennan, PJ; Duque-Correa, MA; García, LF; Obregón-Henao, A; Ortiz, BL; Rojas, M, 2012) |
| "Tuberculosis is a major disease causing every year 1." | ( Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N, 2012) |
| "Active tuberculosis is common among human immunodeficiency virus (HIV)-infected persons living in tuberculosis-endemic areas, but the hazard of subsequent tuberculosis disease has not been quantified in a single prospective cohort." | ( Arbeit, RD; Bakari, M; Horsburgh, CR; Lahey, T; Mackenzie, T; Maro, I; Matee, M; Mtei, L; Pallangyo, K; von Reyn, CF, 2013) |
| "The diagnosis of tuberculosis is seriously hampered in the absence of standard biosafety laboratory facilities for specimen concentration and Mycobacterium tuberculosis culture." | ( Antunes, A; Cardoso, A; David, S; Duarte, EL; Henriques, V; Leite, CQ; Mané, A; Paixão, E; Portugal, C; Salem, JI; Sanca, A; Sancho, L; Sutre, AF, 2012) |
| "Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB)." | ( Abrahams, KA; Alemparte, C; Ballell, L; Barros, D; Besra, GS; Constantinidou, C; Cox, JA; Fernández, R; Loman, NJ; Pallen, MJ; Remuiñán, MJ; Spivey, VL, 2012) |
| "Treatment of tuberculosis is a complex process due to various factors including a patient's inability to persevere with a combined treatment regimen, the difficulty in eradicating the infection in immune-suppressed patients, and multidrug resistance (MDR)." | ( Bukhari, SN; Franzblau, SG; Jantan, I; Jasamai, M, 2013) |
| "Childhood tuberculosis is a neglected aspect of the tuberculosis epidemic." | ( Basagoudar, SS; Jayaram, S; Joseph, N; Nelliyanil, M; Patil, DC; Sharada, MP, 2012) |
| "Tuberculosis is known to induce and exacerbate SLE and it becomes quite difficult to diagnose tuberculosis in this setting, owing to a similar, overlapping presentation of tuberculosis and SLE." | ( Aggarwal, P; Dev, N; Kumar, G; Kumar, N, 2013) |
| "Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M." | ( Ato, M; Fukuda, T; Hamasaki, M; Kinoshita, T; Kobayashi, K; Maeda, Y; Matsumoto, S; Matsumura, T; Morita, YS; Murakami, Y; Nishiuchi, Y; Yoshimori, T, 2013) |
| "Gastric tuberculosis is an uncommon manifestation of extra-pulmonary tuberculosis infection." | ( Alborzi, A; Ghadimi Moghadam, A; Monabati, A; Pouladfar, G, 2013) |
| "Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB)." | ( Afari, J; Alemparte, C; Angulo-Barturen, I; Ballell, L; Barros, D; Besra, GS; Cacho, M; Cammack, N; Constantinidou, C; Dow, DJ; Esquivias, J; Fraile-Gabaldón, MT; González, C; Jiménez, E; Loman, NJ; Martínez-Hoyos, M; Mehta, N; Mendoza-Losana, A; Minick, DJ; Ortega-Muro, F; Pallen, MJ; Pérez-Herrán, E; Rebollo-López, MJ; Remuiñán, MJ; Rullás, J; Sousa, V; Spivey, VL, 2013) |
| "Mycobacterium tuberculosis is the causative agent of tuberculosis, which is becoming an increasingly global public health problem due to the rise of drug-resistant strains." | ( Chim, N; Contreras, H; Goulding, CW; Graves, AB; Harmston, CA; Iniguez, A; Liptak, MD; Owens, CP, 2013) |
| "Tuberculosis is a devastating disease that accounts for a high proportion of infectious disease morbidity and mortality worldwide." | ( Deffur, A; Mulder, NJ; Wilkinson, RJ, 2013) |
| "tuberculosis is worthy of further investigation." | ( Chen, H; Chen, Q; Deng, H; Gong, F; Hu, S; Huang, H; Ma, J; Shi, C, 2013) |
| "Tuberculosis is a bacterial disease that predominantly affects the lungs and results in extensive tissue pathology." | ( Barry, CE; Dartois, V, 2013) |
| "Tuberculosis is the most prevalent infection worldwide." | ( Anupurba, S; Mathuria, BL; Mathuria, JP; Ojha, SK; Samaria, JK; Srivastava, GN, 2013) |
| "tuberculosis is able to partially compensate for defective CCM by upregulation of the cytochrome bd oxidase exposes a functional role of this alternative terminal oxidase under normal aerobic conditions and during pathogenesis." | ( Ehrt, S; Ioerger, TR; Kana, BD; Park, SW; Sacchettini, JC; Small, JL, 2013) |
| "Tuberculosis is a severe infectious disease currently being treated with drugs that were developed more than 40 years ago." | ( Bastos, MM; Boechat, N, 2013) |
| "Tuberculosis is the second leading cause of death from infectious disease." | ( Damiani, G; Federico, B; Furia, G; Laurenti, P; Raponi, M; Ricciardi, W, 2013) |
| "Tuberculosis is a major cause of death among adults infected by HIV." | ( Borand, L; Chea, P; Leng, C; Marcy, O; Nerrienet, E; Pheng, P; Roat Men, N; Saman, M; Sarady Ay, S; Suom, S, 2013) |
| "Mycobacterium tuberculosis is included among a select group of bacteria possessing the capacity for de novo biosynthesis of vitamin B12, the largest and most complex natural organometallic cofactor." | ( Gopinath, K; Mizrahi, V; Moosa, A; Warner, DF, 2013) |
| "tuberculosis is one of five putative permeases for carbohydrate uptake, and is genetically predicted to be an sn-glycerol 3-phosphate importer." | ( Bartlam, M; Jiang, D; Jin, J; Rao, Z; Zhang, Q; Zheng, Q; Zhou, H; Zhou, W, 2014) |
| "Tuberculosis is considered to be one of the major health problem not only in the less developed countries but in the economically developed countries as well." | ( Bánhegyi, P; Baska, F; Breza, N; Greff, Z; Hegymegi-Barakonyi, B; Kéri, G; Németh, G; Orfi, L; Pató, J; Szántai-Kis, C; Székely, ER; Zsákai, L, 2013) |
| "Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis that is responsible for almost 1." | ( Arnold-Schrauf, C; Berod, L; Freitag, J; Gentilini, MV; Holzmann, B; Kruse, F; Sparwasser, T; Stüve, P; Swallow, M, 2014) |
| "Tuberculosis is epidemic among workers in South African gold mines." | ( Chaisson, RE; Churchyard, GJ; Coetzee, L; Corbett, EL; Fielding, KL; Godfrey-Faussett, P; Grant, AD; Hayes, RJ; Lewis, JJ, 2014) |
| "Tuberculosis is still a global health problem all over the world despite its mortality has been decreased with effective treatment regimens." | ( Cinel, G; Çobanoğlu, N; Doğru, D; Göçmen, A; Kiper, N; Köse, M; Koyun, M; Özçelik, U; Pekcan, S; Tana Aslan, A; Yalçın, E, 2013) |
| "Mycobacterium tuberculosis is the causative agent of tuberculosis, killing millions of people every year." | ( Butler-Wu, S; Darwin, KH; Festa, RA; Ioerger, TR; Sacchettini, JC; Samanovic, MI; Shi, X, 2014) |
| "HIV is the top and tuberculosis is the second leading cause of death from infectious disease worldwide, with an estimated 8." | ( Chiappini, E; de Martino, M; Galli, L; Thorne, C; Turkova, A; Venturini, E, 2014) |
| "Mycobacterium tuberculosis is an intracellular pathogen." | ( Bottai, D; Brosch, R; Caire-Brandli, I; de Chastellier, C; Dumas, A; Gouzy, A; Guerquin-Kern, JL; Larrouy-Maumus, G; Levillain, F; Neyrolles, O; Poincloux, R; Poquet, Y; Schnappinger, D; Sório de Carvalho, LP; Wallach, JB; Wu, TD, 2014) |
| "Tuberculosis is five to six times more common among diabetics than among non-diabetics and causes greater morbidity, according to reports." | ( Arora, VK; Chachra, V, 2014) |
| "Primary glans penis tuberculosis is a rare disease, but we must consider it (both primary and secondary forms) to try to avoid diagnostic delays that may cause prejudice for the patient." | ( Alvarez Bandres, S; Garcia Garcia, D; Jimenez Calvo, J; Jimenez Parra, JD; Sotil Arrieta, A; Torres Varas, L, 2014) |
| "Tuberculosis is an ancient disease that is still present as a global public health problem." | ( Batista, AA; Chorilli, M; da Silva, MM; da Silva, PB; de Freitas, ES; de Oliveira Lopes, E; Leite, CQ; Pavan, FR, 2014) |
| "On the other hand, tuberculosis is common in transplant recipients, especially in developing countries, like India." | ( Gundlapalli, S; Gupta, KL; Kaur, H; Kohli, HS; Kumar, V; Mohindra, S; Ramachandran, R; Rathi, M; Sakhuja, V, 2014) |
| "tuberculosis is associated with mutations in the QRDR of gyrA gene; however, the level of OFX resistance may not be predicted based on the mutation patterns in the gyrA gene." | ( Dixit, P; Jain, A; Jaiswal, I; Prakash, S; Singh, M; Singh, P; Venkatesh, V, 2015) |
| "Tuberculosis is endemic in Cape Town, South Africa where a majority of the population become tuberculosis infected before adulthood." | ( Andrews, JR; Ginsberg, S; Kalil, D; Morrow, C; Piccoli, E; Sassi, A; Walensky, RP; Wood, R, 2014) |
| "Congenital tuberculosis is diagnosed by Cantwell criteria and treatment includes three or four anti-tubercular drug regimen." | ( Das, S; Faridi, MM; Mittal, H, 2014) |
| "Recurrent tuberculosis is a major health burden and may be due to relapse with the original strain or reinfection with a new strain." | ( Banda, L; Chiwaya, A; Clark, TG; Coll, F; Crampin, AC; Glynn, JR; Guerra-Assunção, JA; Harris, D; Houben, RM; Khan, P; Mallard, K; McNerney, R; Mzembe, T; Parkhill, J; Pereira, RP, 2015) |
| "Mycobacterium tuberculosis is able to synthesize molybdopterin cofactor (MoCo), which is utilized by numerous enzymes that catalyze redox reactions in carbon, nitrogen, and sulfur metabolism." | ( Kana, BD; Kaplan, G; Manca, C; Mizrahi, V; Orme, IM; Peixoto, B; Shanley, CA; Williams, MJ; Zilavy, A, 2015) |
| "Tuberculosis is one of the most threatening infectious diseases to public health all over the world, for which Mycobacterium tuberculosis (MTB) is the etiological agent of pathogenesis." | ( Jang, WS; Lee, BE; Nam, KW; Podder, B; Song, HY, 2015) |
| "Tuberculosis is one of the leading global health issues responsible for a significant mortality." | ( Kumar, R; Sharma, AK; Sharma, R; Talukdar, D, 2014) |
| "Tuberculosis is continuing as a problem of mankind." | ( Banerjee, D; Bhattacharyya, R; Chakraborty, S; Syal, K, 2015) |
| "Tuberculosis is a contagious disease with comparatively high mortality worldwide." | ( Budagumpi, S; Keri, RS; Nagaraja, BM; Patil, SA, 2015) |
| "Mycobacterium tuberculosis is a facultative intracellular pathogen that thrives inside host macrophages." | ( Mitra, A; Neyrolles, O; Niederweis, M; Wolschendorf, F, 2015) |
| "canettii" and M." | ( Besra, GS; Bhatt, A; Donoghue, HD; Lee, OY; Minnikin, DE; Nataraj, V; Rothschild, BM; Spigelman, M; Wu, HH, 2015) |
| "Human tuberculosis is a chronic infectious disease affecting millions of lives." | ( Eng, WS; Guddat, LW; Hocková, D; Janeba, Z; Keough, DT; Naesens, LM; Špaček, P; West, NP; Woods, K, 2015) |
| "Bovine tuberculosis is one of the important diseases of dairy and wild animals." | ( Akhtar, F; Akhtar, P; Aslam, MS; Cagiola, M; Hussain, SM; Javed, MT; Kausar, R; Khan, MN; Qamar, M, 2015) |
| "Tuberculosis is the most serious infectious disease caused by a single organism, Mycobacterium tuberculosis (Mtb)." | ( Dhillon, J; Durham, PG; Fourie, PB; German, N; Hickey, AJ; Mitchison, DA; Mortensen, N; Zhang, Y, 2015) |
| "Tuberculosis is a leading killer of lives worldwide and the global curse of multi-drug resistant tuberculosis is attaining really dangerous levels." | ( Keum, YS; Park, SW; Patel, RV, 2015) |
| "Tuberculosis is a major global health problem for which improved therapeutics are needed to shorten the course of treatment and combat emergence of drug resistance." | ( Clemens, DL; Dillon, BJ; Horwitz, MA; Hwang, AA; Lee, BY; Zink, JI, 2015) |
| "tuberculosis is reported." | ( Bagchi, S; Sharma, A; Wadhwa, P, 2015) |
| "Treatment for tuberculosis is effective with the use of proper antibiotics, but the number of drug-resistant cases is increasing." | ( Alves, LA; Benévolo-de-Andrade, TC; Bisaggio, Rda C; Pinho, RT; Soares-Bezerra, RJ, 2015) |
| "Extrapulmonary tuberculosis is a rare condition determined by Mycobacterium tuberculosis." | ( Budu, VA; Bulescu, IA; Mogoantă, CA; Mühlfay, G; Popp, CG; Schnaider, A; Toma, CL, 2015) |
| "tuberculosis are a major threat to global public health." | ( Adams, JR; Baluya, DL; Brown, AN; Brown, DL; Drusano, GL; Hafner, R; Jambunathan, K; Kwara, A; Louie, A; Mirsalis, JC; Rodriquez, JL, 2015) |
| "Globally, tuberculosis is slowly declining each year and it is estimated that 37 million lives were saved between 2000 and 2013 through effective diagnosis and treatment." | ( Amin, AG; Chatterjee, D; De, P; McNeil, M; Perkins, MD; Valli, E, 2015) |
| "tuberculosis) are imperative to understanding the pathogenic system for pathogenesis requires attention." | ( Meena, LS, 2016) |
| "Tuberculosis is a health problem worldwide with one-third of the population infected with the Mycobacterium tuberculosis bacilli." | ( Guio, H; Levano, KS; Sánchez, C; Tarazona, D, 2015) |
| "Tuberculosis is a serious infectious disease caused by human pathogen bacteria Mycobacterium tuberculosis." | ( Bdzhola, VG; Golub, AG; Gudzera, OI; Kovalenko, OP; Kriklivyi, IA; Lukashov, SS; Starosyla, SA; Tukalo, MA; Volynets, GP; Yaremchuk, AD; Yarmoluk, SM, 2016) |
| "Mycobacterium tuberculosis is an extremely successful intracellular pathogen that has evolved a broad spectrum of pathogenic mechanisms that enable its manipulation of host defense elements and its survival in the hostile environment inside phagocytes." | ( Brzostek, A; Dziadek, B; Dziadek, J; Fol, M; Grzybowski, M; Krupa, A; Kryczka, J; Kurdowska, A; Plocinski, P, 2016) |
| "Choroidal tuberculosis is present in 5-20% of patients with disseminated tuberculosis, and point-of-care dilated binocular indirect ophthalmoscopy eye examination can provide immediate diagnosis." | ( Ford, N; Heiden, D; Keenan, JD; Lowinger, A; McCune, J; Rao, NA; Saranchuk, P; Yen, M, 2016) |
| "Tuberculosis is one of the leading causes of morbidity and mortality in developing countries." | ( Donkor, S; Mendy, J; Ota, MO; Owolabi, O; Sutherland, JS; Togun, T, 2016) |
| "tuberculosis are a nonreplicating phenotype and accumulation of lipid inclusions in response to hypoxic conditions." | ( Bader, JS; Kirschner, DE; Linderman, JJ; Matern, WM; Pienaar, E, 2016) |
| "Mycobacterium tuberculosis is a human respiratory pathogen that causes the deadly disease tuberculosis." | ( Anderson, WF; Filippova, EV; Kieser, KJ; Kiryukhina, O; Luan, CH; Rubin, EJ; Wawrzak, Z, 2016) |
| "tuberculosis) is considered innately resistant to β-lactam antibiotics." | ( Aharonov, R; Bishai, WR; Cohen, KA; Conway, TC; El-Hay, T; Goldschmidt, Y; Munsamy, V; Pym, AS; Shaham, O; Weissbrod, O; Wyres, KL; Yanover, C, 2016) |
| "Mycobacterium tuberculosis is a successful intracellular pathogen." | ( Baulard, A; Brodin, P; Chamaillard, M; Deboosère, N; Debrie, AS; Deloison, G; Delorme, V; Iantomasi, R; Jouny, S; Locht, C; Queval, CJ; Redhage, K; Song, OR; Veyron-Churlet, R, 2016) |
| "Hepatitis, HIV and tuberculosis are significant and costly public health problems that disproportionately affect individuals with substance use disorders (SUDs)." | ( Heil, SH; Herrmann, ES; Higgins, ST; Matusiewicz, AK; Sigmon, SC; Stitzer, ML, 2017) |
| "tuberculosis is known to cause detectable mycobacteremia." | ( Cobelens, FG; de Jong, BC; Joloba, ML; Meehan, CJ; Ssengooba, W, 2016) |
| "Mycobacterium tuberculosis is still a major health problem throughout the world, especially in developing countries." | ( Bilgin, K; Günaydin, M; Karadağ, A; Odabaşi, H; Taş, H; Yanik, K, 2016) |
| "Mycobacterium tuberculosis is a serious global infectious pathogen causing tuberculosis (TB)." | ( Cheon, SA; Kim, EB; Kim, EJ; Kim, HJ; Ko, S; Lee, J; Lee, MK; Lee, SW; Park, TJ, 2017) |
| "Tuberculosis is classically divided into states of latent infection and active disease." | ( Barry Iii, CE; Coussens, AK; Esmail, H; Flynn, JL; Graham, CM; Koegelenberg, CF; Lai, RP; Lesosky, M; O'Garra, A; Oni, T; Said-Hartley, Q; Walzl, G; Warwick, JM; Wilkinson, KA; Wilkinson, RJ; Young, DB, 2016) |
| "Tuberculosis is an infectious disease and is a major health problem in developing countries like India." | ( Rawal, G; Yadav, S, 2016) |
| "Tuberculosis is a potentially fatal infectious disease caused by Mycobacterium Tuberculosis." | ( Agrawal, A; Duhan, A; Gathwal, M, 2016) |
| "tuberculosis is essential for early management of MDR-TB." | ( Abate, D; Abera, B; Ayele, H; Hailu, T; Mulu, W; Yimer, M, 2017) |
| "tuberculosis is prevalent in both pulmonary and extra-pulmonary tuberculosis patients." | ( Abate, D; Abera, B; Ayele, H; Hailu, T; Mulu, W; Yimer, M, 2017) |
| "Tuberculosis is caused by Mycobacterium tuberculosis and is a devastating disease affecting eight million people each year." | ( Ehrt, S; Lin, K; Mitra, A; Niederweis, M; Speer, A, 2017) |
| "Tuberculosis is a leading killer, especially for people living with HIV." | ( Berisio, R; Romano, M; Ruggiero, A; Squeglia, F, 2017) |
| "Tuberculosis is an infectious communicable disease and the causative agent of the disease has over the years developed resistance to streamline chemotherapeutic agents with dire consequences and there is a need for development of new and more potent alternatives." | ( Bagla, VP; Kabongo-Kayoka, P; Komape, NP; Masoko, P, 2017) |
| "Tuberculosis is a global health problem that causes the death of approximately 1." | ( Jacobs, WR; Kerantzas, CA, 2017) |
| "Tuberculosis is one of the infectious diseases with the greatest global burden, affecting millions of people." | ( Flint, L; Manning, AJ; McGillivray, A; Ovechkina, Y; Parish, T; Roberts, DM, 2017) |
| "Tuberculosis is caused by Mycobacterium tuberculosis, an intracellular pathogen that can survive in host cells, mainly in macrophages." | ( Baranyai, Z; Bősze, S; Dávid, S; Krátký, M; Senoner, Z; Stolaříková, J; Szabó, E; Vinšová, J; Vosátka, R, 2017) |
| "Tuberculosis is a major health problem in the developing world." | ( De, S; Ghosh, MK; Ghosh, TN; Pati, S, 2017) |
| "Tuberculosis is a health problem worldwide." | ( Llerena, C; Murcia, M; Valbuena, A; Zabaleta, A, 2017) |
| "Tuberculosis is the most frequent opportunistic infection and the leading cause of death among persons living with HIV in several low and middle-income countries." | ( Cardoso, SW; da Silva Escada, RO; da Silva Lourenço, MC; Grinsztejn, B; Grinsztejn, E; Marins, LMS; Ribeiro, SR; Velasque, L; Veloso, VG, 2017) |
| "Malaria and tuberculosis are co-endemic in many developing countries." | ( Deme, H; Diack, ND; Diallo, MA; Dieng, M; Diongue, K; Djiba, B; Kane, BS; Ndiaye, D; Pouye, A; Sow, M, 2017) |
| "HIV and M." | ( Alexandrova, L; Andreevskaya, S; Chernousova, L; Khandazhinskaya, A; Kochetkov, S; Margolis, L; Matyugina, E; Smirnova, T; Vanpouille, C; Zicari, S, 2017) |
| "Primary breast tuberculosis is rare." | ( Dong, YJ; Gao, MQ; Huang, YX; Li, Q; Ma, LP; Yang, Q, 2017) |
| "tuberculosis) is the million-dollar question at present." | ( Aarti, C; Barbabosa-Pliego, A; Khusro, A; Salem, AZM, 2018) |
| "Tuberculosis is an important concern following organ transplantation." | ( Fukushima, N; Kuroda, K; Matsuda, S; Nakagita, K; Nakajima, S; Oita, A; Sato, T; Seguchi, O; Shionoiri, A; Sunami, H; Takada, M; Takayoshi, M; Terada, Y; Wada, K; Yanase, M, 2018) |
| "Tuberculosis is a distinctive disease in which the causative agent, Mycobacterium tuberculosis, can persist in humans for decades by avoiding clearance from host immunity." | ( Fieweger, RA; VanderVen, BC; Wilburn, KM, 2018) |
| "Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), a major health issue of the present era." | ( Das, G; Ghodake, G; Gouda, S; Kerry, RG; Patra, JK; Shin, HS; Sil, B, 2018) |
| "Drug resistant tuberculosis is increasing world-wide." | ( Kirschner, DE; Linderman, JJ; Pienaar, E, 2018) |
| "GB tuberculosis is a difficult diagnosis preoperatively." | ( Agrawal, S; Anjum, R; Gupta, A; Mallik, D, 2018) |
| "Tuberculosis is a significant global health threat, with one-third of the world's population infected with its causative agent Mycobacterium tuberculosis (Mtb)." | ( Ahmed, M; Amarasinghe, GK; Artyomov, MN; Balada-Llasat, JM; Bambouskova, M; Chen, L; Howard, NC; Hsu, FF; Khader, SA; Klein, RS; Kreiswirth, BN; Kurepina, N; Loginicheva, E; Marin, ND; Martin, J; Mathema, B; Mitreva, M; Rangel-Moreno, J; Rosa, BA; Sergushichev, A; Torrelles, JB, 2018) |
| "Tuberculosis is the leading infectious cause of death worldwide, and HIV-1 the best recognized risk factor for active TB." | ( Coussens, AK; du Bruyn, E; Esmail, H; Howlett, PJ; Peton, N; Wilkinson, RJ, 2018) |
| "Tuberculosis is the leading cause of death worldwide from infectious diseases." | ( Argyrou, A; Augustyns, K; Balabon, O; Ballell, L; Barros, D; Bates, RH; Blanco-Ruano, D; Cacho, M; Cunningham, F; Huss, S; Lopez-Roman, EM; Pitta, E; Rogacki, MK; Van der Veken, P; Vande Velde, CML, 2018) |
| "tuberculosis is unknown." | ( Joosten, LAB; Koeken, VACM; Kumar, V; Lachmandas, E; Li, Y; Matzaraki, V; Netea, MG; Oosting, M; Riza, A; van Crevel, R, 2019) |
| "Tuberculosis is one of the 10 leading causes of death in the world." | ( Bobadilla-Del-Valle, M; Guerra-De-Blas, PDC; Ponce-De-León-Garduño, A; Sada-Ovalle, I; Sifuentes-Osornio, J; Torres-González, P, 2018) |
| "In today's era tuberculosis is a major threat to human population." | ( Meena, LS, 2019) |
| "Tuberculosis is the leading killer of patients with human immunodeficiency virus (HIV) infection." | ( Andersen, J; Banda, P; Benson, CA; Chaisson, RE; da Silva Escada, RO; Fletcher, CV; Gupta, A; Hakim, J; Jean Juste, MA; Kanyama, C; Lama, JR; Langat, D; Leon-Cruz, J; Masheto, G; Mawlana, S; Mohapi, L; Moran, L; Mwelase, N; Nuermberger, E; Omoz-Oarhe, A; Ramchandani, R; Severe, P; Supparatpinyo, K; Swindells, S; Valencia, J, 2019) |
| "Tuberculosis is a chronic inflammatory disease caused by persistent infection with Mycobacterium tuberculosis." | ( Black, HD; Britton, WJ; Chami, B; Hortle, E; Kaur, A; New, EJ; Oehlers, SH; Robertson, SI; Witting, PK; Xu, W, 2019) |
| "Tuberculosis is the "Achilles heel" of the human immunodeficiency (HIV) ministration." | ( Curreli, F; Debnath, AK; Kini, SG; Kumar, A; Pai, KS; Revathi, R; Sriram, D, 2019) |
| "Tuberculosis is a disease caused by Mycobacterium tuberculosis and is the leading cause of death from a single infectious pathogen, with a high prevalence in developing countries in Africa and Asia." | ( Chavez-Pacheco, SM; de Oliveira, GS; Dias, MVB; Giudice, JHP; Libreros-Zúñiga, GA; Ribeiro, JA; Silva, CDS, 2019) |
| "Tuberculosis is a leading cause of morbidity and mortality in humans worldwide." | ( Bao, R; Dai, M; Guo, M; Huang, ZX; Rao, Y; Wang, X; Yu, Q; Zhang, J, 2019) |
| "Isoniazid resistant tuberculosis is the most prevalent type of resistance in Swaziland and over two-thirds of the isoniazid resistant tuberculosis patients are tuberculosis and human immunodeficiency virus co-infected." | ( Chien, LY; Dlamini, NC; Ji, DD, 2019) |
| "Mycobacterium tuberculosis is a causative organism of tuberculosis, which is the most deadly disease after cancer in the current decade." | ( Choudhari, PB; Dahiwade, LK; Dhavale, RP; More, HN; Rochlani, SP, 2020) |
| "Tuberculosis is a bacterial infectious disease that is usually transmitted by inhalation of droplets containing the bacteria." | ( Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP, 2019) |
| "Tuberculosis is a leading cause of death worldwide." | ( Almeida, AJ; Alves, AD; Gaspar, MM; Grenha, A; Guerreiro, F; Pinho, J; Simões, S, 2020) |
| "Tuberculosis is a devastating disease responsible for approximately 1." | ( Du, Y; Li, J; Liu, J; Lu, N; Ouyang, B; Xia, J; Yang, Y, 2020) |
| "Tuberculosis is the most common cause of death in HIV-infected patients." | ( Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Janzén, D; Sundell, J, 2020) |
| "Tuberculosis is a disease with high incidence and high mortality rate, especially in Brazil." | ( de Sousa, NF; Monteiro, AFM; Rodrigues, GCS; S Maia, M; Scotti, L; Scotti, MT, 2020) |
| "Tuberculosis is caused by the M." | ( Aubry, A; Jaffré, J; Morel, F; Sougakoff, W; Véziris, N, 2020) |
| "Disseminated tuberculosis is characterized with involvement of two or more non-contiguous sites." | ( Garg, R; Garg, RK; Jain, A; Kohli, N; Kumar, N; Malhotra, HS; Pandey, S; Rizvi, I; Sahoo, H; Sharma, PK; Uniyal, R; Verma, R, 2020) |
| "Tuberculosis is the single biggest infectious killer in the world and presents a major global health challenge." | ( Basdeo, SA; Cox, DJ; Gogan, KM; Keane, J; Kenny, C; McQuaid, K; Ó Maoldomhnaigh, C; O'Leary, S; O'Neill, LA; O'Sullivan, MJ; O'Sullivan, MP; Phelan, JJ; Tazoll, SC, 2020) |
| "Tuberculosis is a chronic infectious disease, usually localized in the respiratory system and representing one of the most important global social and biomedical health problems associated with the spread of therapy-resistant forms (multidrug-resistant and extensively drug-resistant tuberculosis)." | ( Bolgarina, AA; Igumnova, OV; Khokhlov, AL; Mariandyshev, AO; Nikitina, NA; Ozerova, IV; Shcherbakova, VS; Smerdin, SV, 2020) |
| "Tuberculosis is the top infectious disease worldwide and the development of a vaccine and diagnostic tools to control the disease is a priority that requires a better understanding of the factors involved in the pathogenesis of Mycobacterium tuberculosis, the infectious agent." | ( Avila, R; Compeán-García, VD; Lopez-Marin, LM; Manisekaran, R; Nava-Mendoza, R; Valdemar-Aguilar, CM, 2020) |
| "Tuberculosis is a highly infectious and potentially fatal disease accompanied by wasting symptoms, which cause severe metabolic changes in infected people." | ( Alia, A; Ding, Y; Egbers, K; Haks, MC; Hankemeier, T; Harms, AC; Joosten, SA; Marín-Juez, R; Ottenhoff, THM; Raterink, RJ; Spaink, HP; van den Eeden, S; Veneman, WJ, 2020) |
| "tuberculosis is carried out to gain further insight into molecular pathogenesis and host-pathogen interaction." | ( Bhattacharyya, K; Bose, M; Brahmachari, V; Joon, M; Nemaysh, V; Pratap, R; Varma-Basil, M, 2020) |
| "M." | ( Lott, JS, 2020) |
| "Tuberculosis is one of the serious universal health threats caused by Mycobacteriumtuberculosis (MTB) and primarily affects the lungs." | ( Dutta, A; Sarma, D, 2020) |
| "Tuberculosis is a serious public health problem aggravated by the slow progress in the development of new anti-tuberculosis drugs." | ( Fu, Y; He, W; Jiang, X; Li, Y; Sun, J; Zhang, Q; Zheng, Y, 2020) |
| "Mycobacterium tuberculosis is one of the hardest to treat bacterial pathogens with a high capacity to develop antibiotic resistance by mutations." | ( Andersson, DI; Hjort, K; Hoffner, S; Jurén, P; Sandegren, L; Toro, JC, 2022) |
| "Tuberculosis is the leading cause of death from a single infectious agent." | ( Alterovitz, G; Teng, L; Zhang, A, 2021) |
| "Tuberculosis is an important opportunist infection that can complicate the posttransplant course of solid-organ transplant recipients." | ( Alameer, R; Almaghrabi, RS; Almohaizeie, A; Alrajhi, AA; Alshehri, N; Nizami, I; Omrani, AS, 2021) |
| "Tuberculosis is a common cause of phlyctenular keratoconjunctivitis, especially for patients who live in a high endemic area of tuberculosis." | ( Apiwattanakul, N; Assawawiroonhakarn, S; Boonsathorn, S; Wiriyachai, T, 2021) |
| "Primary sinonasal tuberculosis is an uncommon cause of phlyctenular keratoconjunctivitis in children." | ( Apiwattanakul, N; Assawawiroonhakarn, S; Boonsathorn, S; Wiriyachai, T, 2021) |
| "Tuberculosis is a devastating and a deadly disease despite the novel advances in its diagnostic tools and drug therapy." | ( Amare, M; Ameni, G; Erko, B; Gashaw, F; Gumi, B; Mekonnen, Y; Yenew, B, 2021) |
| "tuberculosis) is one of the clearest, which is mainly caused by RIF resistance-related mutations in the rpoB gene." | ( Jia, X; Liu, H; Wang, X; Xu, G; Xu, P, 2021) |
| "Tuberculosis is one of the ten major causes of mortality worldwide." | ( Thakur, G; Thakur, H; Thakur, S, 2021) |
| "Myocardial tuberculosis is an exceptionally rare form of extra-pulmonary TB." | ( Ahmed, B; Dey, PK; Khan, MSR; Lutfor Rahman, SM; Momen, MA; Rahman, MM; Rashid, MM; Saifur Rahman, SM, 2021) |
| "Drug resistance in tuberculosis is major threat to human population." | ( Chanda, K; Karuppasamy, R; Rajasekhar, S, 2021) |
| "Colonic tuberculosis is a disease that may mimic many other diseases; therefore, a correct approach is necessary for the correct diagnosis and treatment." | ( Benaissa, E; Benlahlou, Y; Bssaibis, F; Chadli, M; Elouennass, M; Maleb, A; Marjane, S, 2021) |
| "although resistant tuberculosis is not a problem in the scenario, the study showed an increase in its incidence, which puts it on alert." | ( Alves, YM; Arcêncio, RA; Berra, TZ; Bruce, ATI; Giacomet, CL; Ramos, ACV, 2021) |
| "Tuberculosis is one of devastating infectious diseases in the world, and early diagnosis and treatment can help overcome this global burden." | ( Chen, CA; Huang, TH; Huang, YJ; Tsai, TT; Yi-Ju Ho, N, 2021) |
| "Tuberculosis is the primary cause of hospital admission in people living with HIV, and the likelihood of death in the hospital is unacceptably high." | ( Bjerrum, S; Chaplin, M; Lederer, P; Nathavitharana, RR; Shah, M; Steingart, KR, 2021) |
| "Tuberculosis is one of the life-threatening diseases globally, caused by the bacteria Mycobacterium tuberculosis." | ( Fatima, Z; Gupta, S; Kumawat, S, 2021) |
| "Multifocal tuberculosis is rare in immunocompetent subjects." | ( Adjadohoun, S; Badarou, S; Biaou, O; Diallo, K; Kpossou, AR; Ngamo, G; Sehonou, J; Sokpon, CNM; Takin, R; Vignon, RK; Yekpè, P, 2021) |
| "The prevalence of tuberculosis is significantly higher among the multidimensional poor compared to the multidimensional non-poor in India." | ( Mohanty, SK; Pathak, D; Vasishtha, G, 2021) |
| "Tuberculosis is an ancient disease of mankind, and its causative bacterium is Mycobacterium tuberculosis." | ( Gong, X; Liu, H; Yang, Y; Zhang, Q; Zhang, Y; Zhao, N, 2022) |
| "Tuberculosis is an infectious disease that affected more than 50 million people and killed 6." | ( Lee, BS; Pethe, K, 2022) |
| "Tuberculosis is a significant health problem in many parts of the world." | ( Budiman, KY; Hidayat, B; Pratiwi, C; Santoso, P; Soekersi, H; Soeroto, AY, 2022) |
| "The drug-resistant tuberculosis care cascade remains persistently challenged by substantial gaps in timely diagnosis and treatment of drug-resistant tuberculosis." | ( Dookie, N; Naidoo, K, 2022) |
| "Tuberculosis is second only to COVID-19 as a cause of death from a single infectious agent." | ( Dean, AS; Floyd, K; Glaziou, P; Ismail, N; Kasaeva, T; Tosas Auguet, O; Zignol, M, 2022) |
| "Mycobacterium tuberculosis is an etiological agent of tuberculosis (TB) known to be a highly contagious disease and is the major cause of mortality from a single infectious agent worldwide." | ( Aditya, A; Budagavi, DP; Chugh, A; Priya, A, 2022) |
| "Tuberculosis is one of the oldest known infectious diseases to mankind, caused by Mycobacterium tuberculosis." | ( Al-Sehemi, AG; Bhaskar, V; Kumar, S; Nair, AS; Pappachen, LK; Parambi, DGT; Rajappan, KP; Sudevan, ST; Zachariah, SM, 2023) |
| "Solitary chest wall tuberculosis is rare." | ( Li, L; Li, Y; Xiao, L, 2022) |
| "Primary psoas tuberculosis is the presence of "Koch's bacillus'' within the iliopsoas muscle caused by hematogenous or lymphatic seeding from a distant site." | ( Abouhareb, R; Alasadi, L; Alrstom, A; Alsuliman, T; Daher, N; Karam, B; Mohandes, AF; Rajab Bek, MW, 2022) |
| "Tuberculosis is a well-known communicable infectious disease and can involve almost any organ of the body." | ( Ahmed, S; Ilyas, F; Jamil, B; Mustahsan, SM, 2022) |
| "Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis mostly affecting the lungs." | ( Basnet, S; Gurung, K; Pant, P; Shrestha, N, 2022) |
| "Tuberculosis is a public health issue." | ( Rajaobelison, T; Rakotoarisoa, AJC; Rakotorahalahy, RNAL; Ralaivao, RA; Ramiliarijaona, L; Randrianandrasana, S, 2021) |
| "Drug resistance in tuberculosis is exacerbating the threat this disease is posing to human beings." | ( Amiri, V; Delorme, V; Ebrahimzadeh, N; Kasaeian, A; Maleki, M; Masoumi, M; Pourazar, S; Sadeghinia, M; Sheikhpour, M, 2022) |
| "Tuberculosis is an infectious air-borne disease and one of the leading causes of death globally among all infectious diseases." | ( Birangal, SR; Das, S; Lobo, M; Ray, R; Shenoy, GG, 2022) |
| "tuberculosis is puzzling." | ( Baldisseri, D; Berger, JM; Gates, MF; Ghiglieri, M; Guo, JJ; Hauk, G; Honrao, C; Imai, Y; Lewis, K; Liang, L; Ma, X; Morrissette, M; Niles, S; Quigley, J; Shahsavari, N; Son, S, 2022) |
| "Tuberculosis is the most common cause of death in HIV-infected individuals." | ( Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Sundell, J, 2022) |
| "Tuberculosis is a disease with serious consequences in terms of morbidity and mortality." | ( Adrian, C; Ceobanu, G; Diaconu, CC; Enache, V; Gheorghe, G; Hortopan, A; Ionescu, VA; Jinga, V, 2022) |
| "tuberculosis) is usually treated by oral antimycobacterial agents, including rifampicin, ethambutol, and pyrazinamide, but the treatment regimen with intravenous and/or intramuscular antimycobacterial agents for patients who cannot take medications orally remains unclear." | ( Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N, 2022) |
| "Tuberculosis is a leading cause of worldwide infectious mortality." | ( Anderson, HR; Ogbonna, EC; Schmitz, KR, 2022) |
| "Tuberculosis is a chronic lethal infectious disease caused by a single pathogen, Mycobacterium tuberculosis (Mtb)." | ( Geng, P; Hong, X; Li, X; Liu, G; Ni, D, 2022) |
| "Tuberculosis is one of the top ten causes of death globally and the leading cause of death from a single infectious agent." | ( Bok, S; Chakraborty, S; Darr, CM; Gangopadhyay, K; Gangopadhyay, S; Huang, Y, 2022) |
| "Tuberculosis is currently still one of the leading causes of death from a treatable pathogen." | ( Haufroid, M; Volkov, AN; Wouters, J, 2023) |
| "Tuberculosis is currently still one of the leading causes of death from a treatable pathogen." | ( Haufroid, M; Volkov, AN; Wouters, J, 2023) |
| "Tuberculosis is currently still one of the leading causes of death from a treatable pathogen." | ( Haufroid, M; Volkov, AN; Wouters, J, 2023) |
| "Abdominal tuberculosis is one of the common extra pulmonary tuberculosis with diverse clinical manifestations." | ( Gopal Teja, R; Kumar Behera, M; Kumar Pati, G; Kumar Sahu, M; Mishra, D; Narayan, J; Nittala, R; Panda, AK; Singh, A, 2022) |
| "Abdominal tuberculosis is one of the common extra pulmonary tuberculosis with diverse clinical manifestations." | ( Gopal Teja, R; Kumar Behera, M; Kumar Pati, G; Kumar Sahu, M; Mishra, D; Narayan, J; Nittala, R; Panda, AK; Singh, A, 2022) |
| "Tuberculosis is a real public health problem in developing countries." | ( Aboubakari, AS; Bombonne, M; Darré, T; Djiwa, T; Douaguibe, B; Kambote, Y; Sama, BM; Simgban, P; Tchaou, M, 2022) |
| "Tuberculosis is a real public health problem in developing countries." | ( Aboubakari, AS; Bombonne, M; Darré, T; Djiwa, T; Douaguibe, B; Kambote, Y; Sama, BM; Simgban, P; Tchaou, M, 2022) |
| "Tuberculosis is still one of the top causes of infection-related death globally." | ( Thangaraju, P; Velmurugan, H; Yella, SST, 2024) |
| "Tuberculosis is the deadliest bacterial disease globally, threatening the lives of millions every year." | ( Alonso-Rodriguez, N; Barz, M; Best, A; Dal, NK; Fenaroli, F; Griffiths, G; Johann, K; Koynov, K; Ojong, J; Redinger, N; Schäfer, G; Schaible, UE; Schmitt, S; Thompson, AM; Wohlmann, J; Zentel, R, 2023) |
| "Tuberculosis is still a major public health problem in India." | ( Arora, S; Dhamnetiya, D; Jha, RP, 2023) |
| "Tuberculosis is the second leading cause of death from infectious diseases worldwide." | ( Aoki, S; Matsunaga, T; Monobe, K, 2023) |
| "Tuberculosis is the leading bacterial killer worldwide." | ( Goddard, R; Imming, P; Richter, A; Seidel, RW, 2023) |
| "Tuberculosis is a serious contagious disease mainly affecting the lungs and is common in the developing countries." | ( Balijepalli, MK; Butti, L; Kandra, N; Masapogu, S; Somarouthu, VS; Uppala, PK; Uttaravalli, U; Vangoori, Y; Varghese, AM, 2023) |
| "Tuberculosis is the leading killer among the chronic single-source infectious diseases." | ( Chen, L; Chen, Y; Han, Z; Hu, S; Liu, H; Liu, J; Ma, L; Sai, N; Wang, K; Wen, Q; Zhang, J; Zhang, Z; Zhou, C; Zhou, X, 2023) |
| "Rifampin-resistant tuberculosis is a leading cause of morbidity worldwide; only one-third of persons start treatment, and outcomes are often inadequate." | ( Andrino, BB; Ashkin, D; Burgos, M; Caloia, LA; Chen, L; Colon-Semidey, A; DeSilva, MB; Dhanireddy, S; Dorman, SE; Dworkin, FF; Easton, AV; Gaensbauer, JT; Ghassemieh, B; Gomez, ME; Goswami, ND; Haley, CA; Hammond-Epstein, H; Horne, D; Jasuja, S; Jones, BA; Kaplan, LJ; Khan, AE; Kracen, E; Labuda, S; Landers, KM; Lardizabal, AA; Lasley, MT; Letzer, DM; Lopes, VK; Lubelchek, RJ; Mihalyov, A; Misch, EA; Murray, JA; Narita, M; Nilsen, DM; Ninneman, MJ; Ogawa, L; Oladele, A; Overman, M; Patricia Macias, C; Peloquin, CA; Peter Cegielski, J; Ray, SM; Ritger, KA; Rowlinson, MC; Sabuwala, N; Schechter, MC; Schiller, TM; Schwartz, LE; Spitters, C; Thomson, DB; Tresgallo, RR; Valois, P, 2023) |
| "Tuberculosis is a challenge in organ transplantation due to the interaction between Anti- Tuberculosis Treatment (ATT) and immunosuppressive drugs, such as Tacrolimus (TAC)." | ( Ammar, H; Charfi, R; Daghfous, R; Gaies, E; Jebar, HE; Sassi, MB; Trabelsi, S, 2023) |
| "Tuberculosis is a leading infectious disease that has infected one-third of the world's population and is more prevalent among people belonging to developing countries such as India and China." | ( Dong, ML; Lin, ML; Yang, MY, 2023) |
| "Tuberculosis is the leading cause of death from a bacterial infectious disease worldwide." | ( Brehm, TT; Friesen, I; Heyckendorf, J; Kalsdorf, B; Kandulla, J; Köhler, N; Kuhns, M; Lange, C; Martensen, J; Schmiedel, S; Terhalle, E, 2023) |
| "Mycobacterium tuberculosis is an intracellular pathogen that mainly depends on a virulence factor (Mycobacterium tuberculosis protein tyrosine phosphatase B, MptpB) for its survival in the host." | ( Chen, J; Chen, X; Cheng, S; Huang, H; Lu, Y; Tian, J; Wang, B; Ye, F; Zhang, D; Zou, Y, 2023) |
| "Tuberculosis is the number one killer of infectious diseases caused by a single microbe, namely Mycobacterium tuberculosis (Mtb)." | ( Bárta, P; Bouz, G; Doležal, M; Forbak, M; Janďourek, O; Konečná, K; Korduláková, J; Kubíčková, P; Kučera, R; Nawrot, DE; Novák, M; Paterová, P; Pavliš, O; Zemanová, J; Zitko, J, 2023) |
| "Tuberculosis is a disease of poverty, discrimination, and socioeconomic burden." | ( Ahmad, W; Alharbi, JN; Alomary, MN; Alyahya, SA; Ansari, MA; Ansari, SMA; Ather, H; Hani, U; Imran, MA; Islam, N; Jamous, YF; Shoaib, S; Wahab, S, 2023) |
| "Tuberculosis is the leading cause of morbidity and mortality among children living with the human immunodeficiency virus (HIV), mainly in sub-Saharan Africa, including Ethiopia." | ( Asefa, F; Dawit, D; Hawulte, B; Mohammed, H; Oljira, L; Tekese, D, 2023) |
| "Mycobacterium tuberculosis is exposed to diverse stresses inside the host during dormancy." | ( Ajay Kumar, R; Gopi Reji, J; K Edison, L; Kurthkoti, K; Pushparajan, AR; Raghunandanan, S, 2023) |
| "Tuberculosis is one of the major causes of death worldwide; more than a million people die every year because of this infection." | ( Andrés Libreros-Zúñiga, G; Cristina de Moraes Roso Mesquita, N; de Morais Barroso, V; Fehelberg Pinto Braga, S; Ishida, K; Oliva, G; Pavão E Pavão, D; Salgado Ferreira, R; Vinicius Bertacine Dias, M, 2024) |
| Excerpt | Reference |
|---|
| "Tuberculosis has emerged as an epidemic fueled by the large number of individuals infected with the human immunodeficiency virus, especially those who are injecting drug users." | ( Nakata, K; Rom, WN; Weiden, M; Zhang, Y, 1995) |
| "Tuberculosis has been increasing especially in urban areas and in immunosuppressed patients; however, the incidence and factors associated with tuberculosis in OLT patients are unknown." | ( Halpern, M; Mendelson, MH; Meyers, BR; Miller, C; Neibart, E; Sheiner, P, 1994) |
| "tuberculosis have katG deletion, katG sequences in 80 randomly selected isolates from New York City were analyzed." | ( Guan, L; Kornblum, J; Kreiswirth, B; Laraque, F; Riegler, N; Riley, LW; Stoeckle, MY; Weitzman, I, 1993) |
| "tuberculosis has a lipid-rich cell envelope which contributes to the virulence and immunomodulatory properties." | ( Abe, C; Chaicumpar, K; Fujiwara, N; Hotta, H; Nishimura, O; Pan, JW; Takahashi, M; Yano, I, 1997) |
| "Treatment of tuberculosis has three major goals: healing the patient, preventing selection of resistant strains and control transmission of tuberculosis." | ( Dautzenberg, B; Jouveshomme, S, 1997) |
| "tuberculosis have reaffirmed tuberculosis as a primary public health threat." | ( Anderson, SW; Arain, TM; Baker, WR; Barry, CE; Kreiswirth, BN; Langhorne, MH; McMurray, DN; Sherman, DR; Stover, CK; Towell, JA; VanDevanter, DR; Warrener, P; Yuan, Y, 2000) |
| "tuberculosis has transcriptional activity." | ( Butcher, PD; Coates, AR; Dhillon, J; Hu, Y; Mangan, JA; Mitchison, DA; Sole, KM, 2000) |
| "Mycobacterium tuberculosis has two genes for ferric uptake regulator orthologues, one of which, furA, is situated immediately upstream of katG encoding catalase-peroxidase, a major virulence factor that also activates the prodrug isoniazid." | ( Cole, ST; Deretic, V; Domenech, P; Honoré, N; Pym, AS; Song, J, 2001) |
| "The epidemiology of tuberculosis has changed dramatically over the past 5 years with significant shifts in at-risk populations, resulting in increased disease among young adults and children, especially among those from developing countries." | ( Smith, KC, 2002) |
| "Few studies of vole tuberculosis have been undertaken since then, and little is known about the relationship between M." | ( Begon, M; Bennett, M; Cavanagh, R; De Haas, PE; Ergon, T; Graham, IM; Hart, CA; Koedam, M; Kremer, K; Lambin, X; Roholl, P; Soolingen Dv, Dv, 2002) |
| "Tuberculosis has been a public health problem in India since time immemorial." | ( Chauhan, LS, 2003) |
| "Tuberculosis has been making havoc worldwide with an 11." | ( Singh, MM, 2003) |
| "M." | ( Ahmed, A; Britigan, BE; Olakanmi, O; Schlesinger, LS, 2004) |
| "The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years." | ( Andries, K; Cambau, E; de Chaffoy, D; Göhlmann, HW; Guillemont, J; Hoffner, S; Huitric, E; Jarlier, V; Lee, E; Lounis, N; Neefs, JM; Timmerman, P; Truffot-Pernot, C; Van Gestel, J; Verhasselt, P; Williams, P; Winkler, H; Zhu, M, 2005) |
| "Mycobacterium tuberculosis has two members of the alpha-crystallin (Acr) family of molecular chaperones." | ( Humphreys, IR; Murphy, HN; Newton, SM; Robertson, BD; Stewart, GR; Wilkinson, KA; Wilkinson, RJ; Young, DB, 2005) |
| "tuberculosis has been demonstrated, but the molecules involved in iron uptake are currently unknown." | ( Rodriguez, GM; Smith, I, 2006) |
| "Tuberculosis has claimed its victims throughout much of known human history." | ( Daniel, TM, 2006) |
| "Although tuberculosis has already become uncommon in industrialised countries, is a major burden in many developing countries, including India." | ( Gupta, PC; Pednekar, MS, 2007) |
| "tuberculosis have striking similarities, such as necrosis, mineralization, and hypoxia, to natural infections in humans." | ( Aly, S; Andries, K; Basaraba, RJ; Cantarero, L; Ehlers, S; Hoff, D; Lenaerts, AJ; Orme, IM, 2007) |
| "Tuberculosis has been declared to be a global emergency and the HIV/AIDS is fuelling the epidemic." | ( Chugh, S, 2007) |
| "Prophylaxis against tuberculosis has been recognized as important for preventing clinical forms of tuberculosis, mainly in HIV positive patients." | ( Arbeláez, A; Arbeláez, MP; Arias, SL; Betancourt, G; Gómez, RD; Nagles, J; Peláez, LM; Rojas, C; Velásquez, G; Vélez, L, 2007) |
| "Tuberculosis has plagued humans for ages, and understanding the host defense mechanisms against this pathogen has been a challenge to immunologists for decades." | ( Liu, PT; Modlin, RL, 2008) |
| "Tuberculosis has become a major health problem, in particular with the emergence of extremely drug resistant tuberculosis (XDRTB)." | ( Barrows, LR; Bugni, TS; Gideon, OG; Ireland, CM; Koch, M; Matainaho, T; Noro, JC; Piskaut, P; Pond, CD, 2008) |
| "Mycobacterium tuberculosis has low nitrate reductase activity during aerobic growth (AG), but shows strong hypoxic induction." | ( Modesti, L; Sohaskey, CD, 2009) |
| "Mortality due to tuberculosis has been considerably reduced in Delhi over the years with the Revised National TB Control Programme implementation since 1997." | ( Aggarwal, N; Chandra, S; Dhingra, VK; Vashist, RP, 2009) |
| "M." | ( Barry, CE; Boshoff, HI; Singh, R, 2010) |
| "Not all people with tuberculosis have their HIV status ascertained despite the interaction between these infections." | ( Emerson, CR; Goldberg, H; Post, JJ; Vollmer-Conna, U, 2010) |
| "Studies in M." | ( Bi, J; Wang, H; Xie, J, 2011) |
| "tuberculosis has multiple mechanisms of resisting phagosomal acidification." | ( Bossmann, SH; Ehlers, S; Huff, J; Janik, K; Keller, C; Niederweis, M; Song, H; Walter, K, 2011) |
| "Tuberculosis has been declared a global emergency." | ( Bahrmand, A; Fateh, A; Ghazanfari, M; Hadizadeh Tasbiti, A; Karimi, A; Sakhai, F; Yari, F; Yari, Sh, 2011) |
| "M." | ( Khera, A; Puri, RV; Reddy, PV; Tyagi, AK, 2012) |
| "Tuberculosis has been with mankind since time immemorial." | ( Agarwal, SS; Gupta, A; Jain, DK; Sisodia, RS, 2011) |
| "Multidrug-resistant tuberculosis has emerged as a major threat to tuberculosis control." | ( Bisson, GP; Broeckling, C; Burgos, M; Dobos, K; Karakousis, PC; Lun, DS; Mehaffy, C; Prenni, J; Rifat, D; Weissman, D, 2012) |
| "M." | ( Alonso, S; Dick, T; Lin, W; Pethe, K; Phong, WY; Rao, SP, 2013) |
| "tuberculosis, has been investigated for clinical diagnosis of tuberculosis (TB) but few reports exist of attempts to quantitate TBSA." | ( Cai, G; Franzblau, SG; Jaki, BU; Pauli, GF; Wang, Y, 2013) |
| "M." | ( Chim, N; Contreras, H; Goulding, CW; Graves, AB; Harmston, CA; Iniguez, A; Liptak, MD; Owens, CP, 2013) |
| "tuberculosis has access to glycolytic C3 substrates." | ( Beale, MH; Beste, DJ; Hawkins, ND; McFadden, J; Mendum, TA; Niedenführ, S; Nöh, K; Ward, JL; Wiechert, W, 2013) |
| "tuberculosis has the capacity to regulate core metabolic functions according to B12 availability - whether acquired via endogenous synthesis or through uptake from the host environment - and, therefore, imply that there is a role for vitamin B12 in pathogenesis, which remains poorly understood." | ( Gopinath, K; Mizrahi, V; Moosa, A; Warner, DF, 2013) |
| "Bovine tuberculosis has been tackled for decades by costly eradication programs in most developed countries, involving the laboratory testing of tissue samples from allegedly infected animals for detection of Mycobacterium tuberculosis complex (MTC) members, namely Mycobacterium bovis." | ( Albuquerque, T; Amaro, A; Botelho, A; Costa, P; Couto, I; Cunha, MV; Ferreira, AS; Inácio, J; Viveiros, M, 2013) |
| "tuberculosis has developed to maintain redox homeostasis, including mechanisms to regulate endogenous nitric oxide and carbon monoxide levels." | ( Chim, N; Goulding, CW; Johnson, PM, 2014) |
| "tuberculosis has a unique pathway, the RicR regulon, to defend against Cu toxicity." | ( Butler-Wu, S; Darwin, KH; Festa, RA; Ioerger, TR; Sacchettini, JC; Samanovic, MI; Shi, X, 2014) |
| "Tuberculosis has re-emerged as a worldwide threat, which has motivated the development of new drugs." | ( Basso, LA; Butler, JS; de Mesquita Vieira, FG; Diógenes, IC; Lopes, LG; Sadler, PJ; Santiago, DS; Sousa, EH, 2014) |
| "tuberculosis have been extensively studied, the mechanisms by which mycobacteria capture and metabolize nitrogen, which is another essential constituent of biomolecules, have only recently been revisited." | ( Gouzy, A; Neyrolles, O; Poquet, Y, 2014) |
| "The scenario of tuberculosis has gone deadly due to its high prevalence and emergence of widespread drug resistance." | ( Banerjee, D; Bhattacharyya, R; Chakraborty, S; Sayal, K, 2014) |
| "M." | ( Mitra, A; Neyrolles, O; Niederweis, M; Wolschendorf, F, 2015) |
| "Mycobacterium tuberculosis has a cell envelope incorporating a peptidoglycan-linked arabinogalactan esterified by long-chain mycolic acids." | ( Besra, GS; Bhatt, A; Donoghue, HD; Lee, OY; Minnikin, DE; Nataraj, V; Rothschild, BM; Spigelman, M; Wu, HH, 2015) |
| "tuberculosis have been developed." | ( Awasthi, D; Carreau, A; Goullieux, L; Knudson, SE; Kumar, K; Lagrange, S; Ojima, I; Slayden, RA; Vermet, H, 2015) |
| "tuberculosis has altered iron homeostasis and increased sensitivity to antibiotics and to microbicidal effectors produced by activated macrophages." | ( Pandey, R; Rodriguez, GM; Soteropoulos, P; Subbian, S, 2015) |
| "tuberculosis has evolved heme uptake systems different from the paradigms established by other bacteria." | ( Ehrt, S; Lin, K; Mitra, A; Niederweis, M; Speer, A, 2017) |
| "Tuberculosis has been described as the second great imitator as it can imitate various other disease processes." | ( Jairajpuri, ZS; Jetley, S; Khan, S; Pujani, M; Rana, S, 2017) |
| "Mycobacterium tuberculosis has succeeded as a human pathogen for tens of thousands of years thanks to its ability to resist and adapt to the adverse conditions it encounters upon infection." | ( Aebersold, R; Banaei-Esfahani, A; Collins, BC; Cortes, T; Schubert, OT; Young, DB, 2017) |
| "tuberculosis has been extensively studied which represents unique defence strategies by infecting macrophages." | ( Aarti, C; Barbabosa-Pliego, A; Khusro, A; Salem, AZM, 2018) |
| "Fourteen cases of tuberculosis have since been reported." | ( Duval, C; Fornecker, LM; Gravier, S; Herbrecht, R; Ledoux, MP; Lescuyer, S; Maloisel, F; Mauvieux, L; Natarajan-Amé, S; Toussaint, E, 2019) |
| "tuberculosis has been well studied and rigorously genetically validated providing a solid foundation for medicinal chemistry efforts." | ( Aldrich, CC; Bockman, MR; Mishra, N, 2020) |
| "Tuberculosis has been one of the greatest global health challenges of all time." | ( Gerwick, WH; Hou, XM; Shao, CL; Wang, CY, 2019) |
| "Tuberculosis has been a major health problem worldwide for years; therefore, it is important to develop and produce an effective vaccine against this disease." | ( Amel Jamehdar, S; Amini, Y; Badiee, A; Ghazvini, K; Jaafari, MR; Mansury, D; Nikpoor, AR; Tafaghodi, M, 2019) |
| "Mycobacterium tuberculosis has a unique cell envelope structure and composition, containing a peptidoglycan layer that is essential for maintaining cellular integrity and for virulence." | ( Bhakta, S; Healy, J; Keep, NH; Maitra, A; Martin, LT; Munshi, T; Vollmer, W, 2019) |
| "Although rare, tuberculosis has been reported with biologic treatment against psoriasis in Japan, a tuberculosis medium-burden country." | ( Furue, M; Hayashi, H; Higashi, Y; Hino, R; Imafuku, S; Kaneko, S; Kikuchi, S; Koike, Y; Matsuzaka, Y; Mitoma, C; Miyagi, T; Morizane, S; Nakahara, T; Nakamura, M; Nomura, H; Ohata, C; Ohyama, B; Okazaki, F; Sawada, Y; Sugita, K; Takahashi, K; Tsuruta, N; Yamaguchi, K; Yamaguchi, M; Yanase, T; Yonekura, K, 2020) |
| "tuberculosis have evolved mutations in a previously uncharacterized DnaA pathway that quantitatively increases resistance to the key first-line antibiotic isoniazid." | ( Brown, J; Chao, MC; Culviner, PH; Dulberger, CL; Fortune, SM; Giffen, SR; Hicks, ND; Liu, Q; Sixsmith, J; Stanley, S; Wolf, ID, 2020) |
| "Autochthonous tuberculosis has become rare in Switzerland and the new diagnoses are increasingly attributable to immigration." | ( Altpeter, ES; Schmidt, AJ, 2021) |
| "Tuberculosis has been described as a global health crisis since the 1990s, with an estimated 1." | ( Alberton Perelló, M; Basso, LA; Dornelles, M; Duarte, L; Ev Neves, C; Fries Silva, F; Jardim Etchart, R; Lopes Abbadi, B; Machado, P; Rambo, RS; Souza Macchi, F; Sperotto, N; Valim Bizarro, C; Vescia Lourega, R, 2021) |
| "tuberculosis has made TB management extremely challenging eliciting the urgent need for alternative therapeutics." | ( Aditya, A; Budagavi, DP; Chugh, A; Priya, A, 2022) |
| "Muscular tuberculosis has relatively low prevalence in comparison with other cases of extrapulmonary tuberculosis, which explains the difficulties in establishing the diagnosis." | ( Abouhareb, R; Alasadi, L; Alrstom, A; Alsuliman, T; Daher, N; Karam, B; Mohandes, AF; Rajab Bek, MW, 2022) |
| "tuberculosis have relied on the use of single-gene deletion mutants, raising the possibility that the remaining enzymes could catalyze succinate oxidation in the absence of the other." | ( Adolph, C; Cook, GM; McNeil, MB, 2022) |
| "Tuberculosis has maximum burden among young population in developing countries like India." | ( Bhattacherjee, N; Choudhary, MP; Gupta, A; Singla, R, 2022) |
| "Tuberculosis has maximum burden among young population in developing countries like India." | ( Bhattacherjee, N; Choudhary, MP; Gupta, A; Singla, R, 2022) |
| "Tuberculosis has maximum burden among young population in developing countries like India." | ( Bhattacherjee, N; Choudhary, MP; Gupta, A; Singla, R, 2022) |
| "Tuberculosis has remained a leading cause of death among people living with HIV (PLHIV) globally." | ( Jacobs, C; Maritim, P; Mdoe, P; Nyarubamba, RF; Silumbwe, A; Zulu, JM, 2022) |
| "Tuberculosis has remained a leading cause of death among people living with HIV (PLHIV) globally." | ( Jacobs, C; Maritim, P; Mdoe, P; Nyarubamba, RF; Silumbwe, A; Zulu, JM, 2022) |
| "Tuberculosis has remained a leading cause of death among people living with HIV (PLHIV) globally." | ( Jacobs, C; Maritim, P; Mdoe, P; Nyarubamba, RF; Silumbwe, A; Zulu, JM, 2022) |
| "Drug-resistant tuberculosis has a high mortality rate and is still a serious public health concern around the world." | ( Thangaraju, P; Velmurugan, H; Yella, SST, 2024) |
| "tuberculosis has raised concerns due to the greater difficulties in patient treatment and higher mortality rates." | ( Bonjorno, AF; Campos, DL; Demarqui, FM; Denny, WA; Dos Santos, JL; Fernandes, GFS; Manieri, KF; Nascimento-Junior, NM; Pavan, FR; Ribeiro, CM; Ruiz, DAG; Thompson, AM, 2023) |
| "tuberculosis has five paralogues." | ( Andrés Libreros-Zúñiga, G; Cristina de Moraes Roso Mesquita, N; de Morais Barroso, V; Fehelberg Pinto Braga, S; Ishida, K; Oliva, G; Pavão E Pavão, D; Salgado Ferreira, R; Vinicius Bertacine Dias, M, 2024) |
| Excerpt | Reference |
|---|
| "Drug treatment of tuberculosis is reviewed." | ( Koerner, SK; Pinsker, KL, 1976) |
| "Rifampin is a drug used in the treatment of tuberculosis." | ( Anderson, WH; Katz, DB; Skolnick, JL; Stoler, BS, 1976) |
| "Optimum treatment of tuberculosis in persons with human immunodeficiency virus (HIV) infection is still being defined." | ( Nolan, CM, 1992) |
| "Mean duration of treatment for tuberculosis decreased from 20." | ( Leff, AR; Leff, DR, 1985) |
| "Of those who died before completion of treatment, tuberculosis was the cause of death or contributory in 23 and 16 of the 23 (70 per cent) had been on treatment for less than 13 weeks." | ( Cole, RB; Mackay, AD, 1984) |
| "Author debates the advantages of home treatment of tuberculosis and the question limits." | ( Arizio, A, 1984) |
| "Of the first-line drugs used to treat tuberculosis, i." | ( Davies, PD; Grange, JM; Winstanley, PA, 1994) |
| "The ideal treatment for tuberculosis would supplement a truncated course of chemotherapy with an immunotherapeutic preparation able to down-regulate the Koch phenomenon and replace it with an efficiently bactericidal mechanism." | ( al Attiyah, R; Bahr, G; Corrah, T; Hernandez, H; Ly, HM; Onyebujoh, P; Rook, GA; Stanford, JL; Wilkins, E, 1994) |
| "The authors made an attempt to treat experimental tuberculosis with sodium glutamate and isoniazide under chronic exposure to PAH dust." | ( Kazak, TI; Kleĭn, AV; Nosova, NA; Pavlov, VA, 1995) |
| "Rifampicin was given to treat tuberculosis in four elderly hypertensive patients whose blood pressure was well-controlled by one or more dihydropiridine calcium-channel blockers (nisoldipine, nifedipine, or barnidipine and manidipine), shortly after the start of antituberculosis therapy, their blood pressures rose." | ( Saima, S; Takahashi, M; Yoshimoto, H, 1996) |
| "Physicians who treat tuberculosis require training and support." | ( Geiter, LJ; Hale, BE; Miller, B; Sumartojo, EM, 1997) |
| "To determine whether preventive treatment for tuberculosis in adults infected with HIV reduces the frequency of tuberculosis and overall mortality." | ( Garner, P; Squire, SB; Wilkinson, D, 1998) |
| "Early detection and treatment of tuberculosis are essential to prevent transmission both inside and outside of health-care settings." | ( Chaisson, RE; McAvinue, S, 1991) |
| "All adult patients commenced on treatment for tuberculosis from September 1994 to February 1996 were interviewed on initiation of treatment." | ( Liam, CK; Lim, KH; Tang, BG; Wong, CM, 1999) |
| "To determine the impact of treatment of tuberculosis on plasma HIV-1 load in African subjects and to correlate viral load with response to treatment and changes in immune activation." | ( Acheampong, JW; Butera, ST; Folks, TM; Griffin, GE; Lal, RB; Lawn, SD; Shattock, RJ, 1999) |
| "New short-course regimens for the treatment of latent tuberculosis have been evaluated in the past decade, and are efficacious and associated with better adherence." | ( Chaisson, RE, 2000) |
| "The regimens of treatment for tuberculosis were INH + RFP + EB in 8 cases, INH + RFP + EB + PZA in 7 cases, INH + RFP + SM in 2 cases, INH + RFP + SM + PZA in 1 case, and INH + RFP in 1 case." | ( Abe, T; Kawahara, S; Kobashi, Y; Kuraoka, T; Matsushima, T; Nishimura, K; Okimoto, N; Shigeto, E; Shishido, S; Takeyama, H, 2000) |
| "To determine whether short-course treatment of latent tuberculosis infection (LTBI) with 2 months of rifampin and pyrazinamide (2RZ) is well tolerated and leads to increased treatment completion among jail inmates, a group who may benefit from targeted testing and treatment for LTBI but for whom completion of > or = 6 months of isoniazid treatment is difficult because of the short duration of incarceration." | ( Bock, NN; DeVoe, B; Geiter, LJ; Herron, GD; Rogers, T; Tapia, JR, 2001) |
| "138 newly diagnosed and retreatment pulmonary tuberculosis patients were randomly allocated to receive four chemotherapy regimens." | ( Duan, L; Lu, Y; Zhu, L, 2000) |
| "The patient was successfully treated with antituberculosis agents, and clarithromycin, for presumptive chlamydial infection." | ( Carbonara, S; Costa, D; D'Aprile, A; Maggi, P; Monno, R; Pastore, G; Sibilio, G, 2001) |
| "Symptoms or previous treatment for tuberculosis and suspicion of tuberculous lymphadenopathy were the main reasons for exclusion." | ( Antivelink, L; Brink, A; Elliott, A; French, N; Gilks, C; Lugada, ES; Nakiyingi, J; Nanyunja, M; Watera, C; Whitworth, J, 2002) |
| "Patients treated for tuberculosis with aminoglycosides were evaluated for hearing loss and nephrotoxicity for a minimum of 14 days." | ( de Jager, P; van Altena, R, 2002) |
| "In the long-term treatment of tuberculosis with aminoglycosides, ototoxicity seems to be a greater problem than nephrotoxicity." | ( de Jager, P; van Altena, R, 2002) |
| "Inconsistent or partial treatment of tuberculosis and prescription of the wrong drugs are the root causes of drug resistance." | ( , 1997) |
| "An alternative regimen for the treatment of latent tuberculosis infection is 2 months of rifampin and pyrazinamide, but some patients have died of hepatitis associated with this therapy." | ( Cheng, AC; Engemann, JJ; Fortenberry, ER; Hamilton, CD; Stout, JE, 2003) |
| "Modern treatment for tuberculosis has greatly increased the problem of preventing spread of infection." | ( SCARBOROUGH, CG, 1954) |
| "It is well known that in the treatment of tuberculosis with isoniazid the complication of peripheral neuritis may arise." | ( ANDREWS, RH; DEVADATTA, S; FOX, W; GANGADHARAM, PR; RAMAKRISHNAN, CV; SELKON, JB; VELU, S, 1960) |
| "Under most circumstances, treatment of latent tuberculosis infection with isoniazid is cost-saving than treatment with RZ." | ( Bernardo, J; Daley, CL; Hopewell, PC; Jasmer, RM; Kawamura, LM; King, MD; Saukkonen, JJ; Snyder, DC, 2004) |
| "The emphasis on treatment of latent tuberculosis (TB) infection highlights the tradeoff between short-term decrements in health status from 'preventive' therapy, and long-term gains related to fewer cases of active TB." | ( Bourbeau, J; Dion, MJ; Menzies, D; Schwartzman, K; Tousignant, P, 2004) |
| "To characterize the treatment of latent tuberculosis infection and the impact on treatment completion of the 2-month rifampin and pyrazinamide regimen as compared to the traditional 6- to 12-month isoniazid regimen among persons incarcerated at a county correctional facility." | ( Brannan, GL; Clancey, T; Conklin, TJ; Lincoln, T; Lynch, V; Rose, DN; Tuthill, RJ, 2004) |
| "To study the efficacy of moxifloxacin treatment for tuberculosis, we utilized a novel cartridge system to simulate in vivo pharmacokinetics." | ( Bishai, WR; Ginsburg, AS; Grosset, JH; Hamzeh, FM; Lee, J; Woolwine, SC, 2005) |
| "The concomitant treatment of HIV-tuberculosis co-infection is complicated by pharmacological interactions between drugs, resulting in unpredictable drug levels." | ( Brennan-Benson, P; Harrison, T; Lyus, R; Macallan, D; Pakianathan, M, 2005) |
| "Rifampicin, an important drug in the treatment of tuberculosis, is used extensively despite its broad effects on drug-drug interactions, creating serious problems." | ( Chen, J; Raymond, K, 2006) |
| "Ethambutol is used in the treatment of tuberculosis, which is still prevalent in Southeast Asia, and can be associated with permanent visual loss." | ( Lim, SA, 2006) |
| "Existing data on the effect of treatment of latent tuberculosis infection (LTBI) on T-cell responses to Mycobacterium tuberculosis (MTB)-specific antigens are contradictory." | ( Anzidei, G; Bizzoni, F; Butera, O; Casetti, R; Dainotto, D; Girardi, E; Goletti, D; Ippolito, G; Nisii, C; Parracino, MP; Poccia, F, 2007) |
| "In the treatment of latent tuberculosis infection, a 3-month course of isoniazid plus rifampin resulted in better adherence and a lower percentage of discontinued treatments than a 6-month isoniazid course." | ( Dimas, JF; García, AJ; García, M; Geijo, MP; Herranz, CR; Vaño, D, 2007) |
| "In this study, treatment of latent tuberculosis during transplant candidacy period is explored, and relevant literature is reviewed." | ( Bui, L; Jahng, AW; Joyner, JL; Tran, T, 2007) |
| "Standard treatment of active tuberculosis (TB) consists of isoniazid (INH), rifampin (RMP), pyrazinamide (PZA) and ethambutol (EMB)." | ( Bruchet, N; Elwood, RK; Fitzgerald, JM; Marra, CA; Marra, F; Moadebi, S; Richardson, K, 2007) |
| "Of these, 58 were being treated with anti-tuberculosis chemotherapy consisting of INH, RFP and PZA (HRZ group) and the remaining 49 with INH and RFP (HR group)." | ( Akagawa, S; Ariga, H; Kaneko, Y; Kawabe, Y; Kawashima, M; Kunogi, M; Kurashima, A; Machida, K; Masuda, K; Matsui, H; Matsui, Y; Nagai, H; Nagayama, N; Oshima, N; Shimada, M; Suzuki, J; Tamura, A; Toyoda, E; Yotsumoto, H, 2008) |
| "To study the effect of treatment of latent tuberculosis infection (LTBI) on QuantiFERON TB-2G (QFT-2G) test results." | ( Harada, N; Higuchi, K; Mori, T; Okada, K, 2008) |
| "Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection is rare." | ( Fountain, FF; Jacobs, AR; Self, TH; Tolley, EA, 2009) |
| "Pyrazinamide is a first-line drug for treating tuberculosis, but pyrazinamide resistance testing is usually too slow to guide initial therapy, so some patients receive inappropriate therapy." | ( Caviedes, L; Evans, CA; Gilman, RH; Méndez, M; Moore, DA; Peña, L; Sheen, P; Zhang, Y; Zimic, MJ, 2009) |
| "In order to find out useful FQs for treatment of tuberculosis, the comparative efficacy of five FQs, namely, ofloxacin (OFL), ciprofloxacin (CIP), sparfloxacin (SPX), gatifloxacin (GAT) and levofloxacin (LEVX) was studied against Mycobacterium tuberculosis (MTB) isolates obtained from both treated and untreated patients from Agra and Kanpur regions of north India." | ( Chauhan, DS; Das, R; Faujdar, J; Gupta, P; Jaudaun, GP; Katoch, K; Katoch, VM; Sachan, P; Sachan, S; Sharma, VD; Singh, M; Singh, P; Srivastava, K; Srivastava, RK; Upadhyay, P; Venkatesan, K; Yadav, VS, 2009) |
| "Regimens recommended to treat latent tuberculosis infection (LTBI) are 3 to 9 months long." | ( Grosset, JH; Nuermberger, EL; Rosenthal, IM; Zhang, M; Zhang, T, 2009) |
| "At baseline, 9% of all patients were on treatment for tuberculosis and 3% of women were pregnant." | ( Anglaret, X; Duvignac, J; Gnokoro, J; Karcher, S; Komena, E; Konan-N'dri, E; Messou, E; N'dri-Yoman, T; Seyler, C; Tanoh, A, 2010) |
| "Interestingly, treatment of M." | ( Allie, N; Arendse, H; Estes, DM; Folb, P; Folk, WR; Jacobs, M; Johnson, Q; Mabusela, W; Matika, L; Mukinda, J; Ntutela, S; Smith, P; Steyn, L; Syce, J, 2009) |
| "Strategies for prevention and treatment of tuberculosis infection must take these findings into consideration." | ( Hari, L; Jawahar, MS; Locht, C; Narayanan, PR; Narayanan, S; Narendran, G; Ramachandran, R; Shanmugam, S; Supply, P; Swaminathan, S, 2010) |
| "Drug-treated, M." | ( Antonelli, LR; Bafica, A; Cheever, AW; Feng, CG; Gigliotti Rothfuchs, A; Gonçalves, R; Roffê, E; Salazar, AM; Sher, A, 2010) |
| "There are claims that some can treat tuberculosis." | ( Joloba, M; Kirimuhuzya, C; Odyek, O; Waako, P, 2009) |
| "Among the patients registered for re-treatment of tuberculosis (n = 112), 24 (21." | ( Bhagat, VM; Gattani, PL, 2010) |
| "Isoniazid (INH) is a key agent in the treatment of tuberculosis." | ( Ando, H; Kato, S; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Mori, T, 2011) |
| "Effective treatments for tuberculosis consist of a combination of several drugs administered over long periods of time." | ( Imperial, S; Obiol-Pardo, C; Rubio-Martinez, J, 2011) |
| "Pyrazinamide is important in the treatment of tuberculosis." | ( Boeree, MJ; Dekhuijzen, PN; Mulder, A; Simons, SO; van der Laan, T; van Ingen, J; van Soolingen, D, 2012) |
| "In the modified intention-to-treat analysis, tuberculosis developed in 7 of 3986 subjects in the combination-therapy group (cumulative rate, 0." | ( Bliven-Sizemore, E; Borisov, AS; Bozeman, L; Chaisson, RE; Conde, MB; Gordin, F; Hackman, J; Hamilton, CD; Horsburgh, CR; Kerrigan, A; Menzies, D; Shang, N; Sterling, TR; Villarino, ME; Weiner, M; Weis, SE; Wing, D, 2011) |
| "It is essential to identify and treat contacts of tuberculosis patients with active disease." | ( , 2012) |
| "The cost was the sum of the cost of treating latent tuberculosis infection in all contacts plus the cost of treating tuberculosis in whom the disease was not avoided." | ( Clotet, L; Domínguez, A; Ferrer, A; Garrido, P; Pina, JM; Sala, MR; Salleras, L, 2013) |
| "Information on the diagnosis and treatment of tuberculosis was abstracted from medical records." | ( Bositis, C; Hamangaba, F; Moss, WJ; Sutcliffe, CG; van Dijk, JH; Watson, DC, 2013) |
| "Forty-five children treated for tuberculosis initiated an EFV-based regimen and 69 children initiated a NVP-based regimen, 7 of whom also were treated for tuberculosis." | ( Bositis, C; Hamangaba, F; Moss, WJ; Sutcliffe, CG; van Dijk, JH; Watson, DC, 2013) |
| "Relevant patents concerning combined treatment of tuberculosis are analyzed." | ( de Souza, MV; Pinheiro, AC, 2013) |
| "The standard treatment for tuberculosis (TB) is the key to its control." | ( , 2013) |
| "Our patient has been treated with antituberculosis therapy, corticosteroids, methotrexate, and rituximab to control her continued active vasculitis." | ( Adams, A; Aguiar, CL; Barinstein, L; Dayton, JD; Lehman, TJ; Macdermott, EJ; Salvatore, C; Thimmappa, N; Walters, HM, 2013) |
| "Pyrazinamide (PZA) is a key drug in the treatment of tuberculosis (TB), including multidrug-resistant TB." | ( Angeby, K; Hoffner, S; Johansson, A; Jönsson, B; Sellin, M; Sturegård, E; Werngren, J, 2013) |
| "The need to develop new, improved treatments for tuberculosis (TB) remains urgent, and the repurposing of existing drugs represents a possible shortcut to market." | ( Bruiners, N; Gennaro, ML; Karakousis, PC; Pine, R; Pinn, ML; Skerry, C, 2014) |
| "The optimal treatment for tuberculosis (TB) in human immunodeficiency virus (HIV) infected patients in resource-poor settings receiving lopinavir-ritonavir (LPV/r) based second-line antiretroviral therapy (ART) has yet to be determined." | ( Chelin, N; Cohen, S; Gandhi, RT; Murphy, RA; Sunpath, H; Tennant, I; Winternheimer, P, 2014) |
| "Concomitant treatment of tuberculosis (TB) and HIV is recommended and improves outcomes." | ( Dooley, KE; Karlsson, MO; Svensson, EM, 2014) |
| "Here, we found that pretreatment of M." | ( Bhattacharjee, O; Das, S; Goswami, A; Majumdar, S; Pal, NK, 2015) |
| "Despite efforts to detect and treat active tuberculosis (TB) at the border, 75% of all active TB cases diagnosed in our hospital were illegal migrants." | ( Abu-Hanna, J; Aviram, G; Braun, T; Carmeli, Y; Grisaru-Soen, G; Lessing, JB; Schechner, V, 2015) |
| "We show that treatment of M." | ( Abramovitch, RB; Champion, PA; Colvin, CJ; Johnson, BK; Mba Medie, F; Needle, DB, 2015) |
| "Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs." | ( Andersen, JW; Bao, Y; Benson, CA; Chaisson, RE; Fletcher, CV; Gupta, A; Kim, P; Mohapi, L; Mwelase, T; Podany, AT; Supparatpinyo, K; Swindells, S, 2015) |
| "Effective treatment of tuberculosis during pregnancy is essential for preventing maternal and fetal mortality, but little is known about the effects of pregnancy on the disposition of antituberculosis drugs." | ( Castel, S; Chaisson, RE; Cohn, S; Denti, P; Dooley, KE; Hoffmann, J; Martinson, N; Mashabela, F; McIlleron, H; Msandiwa, R; Wiesner, L, 2015) |
| "The first-line of treatment for tuberculosis includes the drugs Isoniazid (INH) and Rifampicin (RIF) metabolized in the liver." | ( Guio, H; Levano, KS; Sánchez, C; Tarazona, D, 2015) |
| "Targeted diagnosis and treatment of latent tuberculosis (TB) infection (LTBI) among persons with a high risk of exposure to TB or of developing TB when infected has been performed and monitored routinely in the Netherlands since 1993." | ( Cobelens, F; de Vries, G; Erkens, CG; Schimmel, H; Slump, E; van den Hof, S; Verhagen, M, 2016) |
| "Screening for and treating tuberculosis (TB) infection in children and adolescents is an effective way of decreasing future TB cases." | ( Cruz, AT; Graviss, EA; Hatzenbuehler, LA; Smith, EO; Starke, JR, 2016) |
| "Traditional treatment of tuberculosis infection (TBI) is efficacious, but adherence is low." | ( Cruz, AT; Starke, JR, 2016) |
| "Ineffectively treated tuberculosis (TB) is associated with substantial morbidity and mortality." | ( Corelli, F; Frosini, M; Saponara, S; Sgaragli, G, 2016) |
| "Patients treated for tuberculosis (TB) who had rifampicin (RMP) or isoniazid (INH) concentrations measured between 1 January 2005 and 31 December 2012 were studied retrospectively." | ( Chiu, W; Hu, R; Lewis, C; Maze, MJ; Nisbet, M; Paynter, J, 2016) |
| "We identified significant gaps in the treatment for M." | ( Bolan, R; Chang, AH; Dubé, MP; Ghosh, JK; Kerndt, PR; Shin, SS; Yang, OO, 2016) |
| "Chemical treatments of M." | ( Abate, G; Chatterjee, D; De, P; Dobos, KM; Hesser, DC; Hoft, DF; Kirkwood, JS; Sakala, IG; Spencer, CT; Xia, M, 2016) |
| "Decentralization of Directly Observed Treatment (DOT) for tuberculosis (TB) to the community (home-based DOT) has improved the coverage of TB treatment and reduced the burden to the health care facilities (facility-based DOT)." | ( Chiryamkubi, M; Fenner, L; Gagneux, S; Hella, J; Kisandu, S; Maroa, T; Mhalu, G; Mhimbira, F; Mkopi, A; Mutayoba, B; Reither, K; Said, K, 2016) |
| "The approval of bedaquiline to treat tuberculosis has validated adenosine triphosphate (ATP) synthase as an attractive target to kill Mycobacterium tuberculosis (Mtb)." | ( Alcock, P; Ambady, A; Ashton, H; Balakrishnan, G; Balasubramanian, V; Bharath, S; Bhat, J; Collier, M; Cooper, CB; Dinesh, N; Gupta, AK; Guptha, S; Hameed P, S; Hosagrahara, VP; Iyer, P; Kandaswamy, K; Kaur, P; Kavanagh, S; Kedari, C; Mallya, M; Markad, SD; McLaughlin, RE; Mdluli, K; Mudugal, NV; Mukherjee, K; Murray, D; Nanduri, R; Narayan, A; Narayanan, S; Naveen Kumar, CN; Naylor, K; Panda, M; Panduga, V; Plant, D; Plant, H; Prabhakar, KR; Preston, M; Raichurkar, A; Ramachandran, V; Ravishankar, S; Reddy, J; Rich, K; Rubin, H; Rudrapatna, S; Sambandamurthy, VK; Saralaya, R; Shandil, R; Sharma, S; Shinde, V; Solapure, S; Tantry, SJ; Walsh, J; Whiteaker, J; Yano, T, 2017) |
| "New and improved treatments for tuberculosis (TB) are urgently needed." | ( Delorme, V; Jang, J; Jeong, J; Kim, G; Kim, R; Park, DE; Woo, M, 2017) |
| "Effective treatment for tuberculosis (TB) patients on first-line treatment involves triaging those with drug-resistant (DR) TB to appropriate treatment alternatives." | ( Brandeau, ML; Goldhaber-Fiebert, JD; Suen, SC, 2018) |
| "In the treatment of murine tuberculosis, a rifampicin dose of 30 mg/kg was sufficient to eradicate persistent M." | ( Alameda-Martin, L; Coates, A; Davies, G; Harrison, T; Hu, Y; Liu, Y; Ortega-Muro, F; Pertinez, H, 2018) |
| "The traditional treatment of tuberculosis (TB) infection (9 months of daily isoniazid [9H]) is safe but completion rates of <50% are reported." | ( Cruz, AT; Starke, JR, 2018) |
| "Ensuring adherence and support during treatment of tuberculosis (TB) is a major public health challenge." | ( Bastos, M; Falzon, D; Mappin-Kasirer, B; Nsengiyumva, NP; Oxlade, O; Schwartzman, K; Trajman, A, 2018) |
| "Dosing recommendations for treating childhood tuberculosis (TB) were revised by the World Health Organization, yet so far, pharmacokinetic studies that have evaluated these changes are relatively limited." | ( Augustino, D; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kibiki, GS; Kivuyo, S; Mduma, E; Mfinanga, S; Mmbaga, B; Nicodemu, I; Peloquin, CA; Thomas, TA; Yeconia, A; Zagurski, T, 2020) |
| "As current treatment of tuberculosis is burdensomely long, provoking non-adherence and drug resistance, effective short-course treatments are needed." | ( Clemens, DL; Dillon, BJ; Ho, CM; Horwitz, MA; Lee, BY; Masleša-Galić, S; Nava, S; Silva, A, 2018) |
| "The concurrent treatment of tuberculosis and human immunodeficiency virus (HIV) is challenging, owing to drug interactions, overlapping toxicities, and immune reconstitution inflammatory syndrome (IRIS)." | ( Aboud, M; Ait-Khaled, M; Angelis, K; Belonosova, E; Brown, D; Dooley, KE; Grinsztejn, B; Kaplan, R; Keegan, MR; Lacerda, M; Mwelase, N; Singh, R; Sued, O; Talarico, CL; Tenorio, AR; Ticona, E, 2020) |
| "Effective therapeutic regimens for the treatment of tuberculosis (TB) are limited." | ( Biswas, R; Mohan, CG; Nair, SS; Nair, SV; Pushkaran, AC; Vanuopadath, M; Vasudevan, AK; Vinod, V, 2019) |
| "Among over 8000 patients treated for latent tuberculosis we found no evidence of acquired drug resistance, underscoring the safety of rifampin monotherapy for latent tuberculosis." | ( Aiona, K; Belknap, R; Flynn, AG; Haas, MK; Reves, R, 2020) |
| "New effective compounds to treat tuberculosis are urgently needed." | ( Abbadi, BL; Basso, LA; Bizarro, CV; Bondan da Silva, J; Machado, P; Picada, JN; Pissinate, K; Rodrigues-Junior, VS; Sperotto, NDM; Villela, AD, 2020) |
| "Of 108 pregnant women treated for MDR/RR-tuberculosis, 88 (81%) were living with human immunodeficiency virus." | ( Chotoo, S; Green, N; Hlangu, S; Hughes, J; Loveday, M; Master, I; Reddy, T; Seddon, JA; Sunkari, B, 2021) |
| "Traditionally children have been treated for tuberculosis (TB) based on data extrapolated from adults." | ( Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G, 2020) |
| "Current strategies to treat tuberculosis (TB) and co-morbidities involve multidrug combination therapies." | ( Dyavar, SR; Fletcher, CV; Mykris, TM; Podany, AT; Scarsi, KK; Winchester, LC, 2020) |
| "Benzo(c)thiophene-1,3-dione treatment of tuberculosis mice model effectively inhibited pulmonary CFU compared to model group." | ( Chang, L; Hu, J; Jiang, Y; Liu, F, 2020) |
| "After completion of treatment of Tuberculosis (TB), many patients can have long-term physical sequelae, which in some cases results in life-long impairment and further stigma." | ( Dhikale, PT; Kalaiselvan, G; Rajalakshmi, M; Sudhakar, R, 2020) |
| "Rifampicin is a key drug for the treatment of tuberculosis (TB)." | ( Chung, JY; Kim, ES; Kwon, BS; Lee, JH; Park, JS; Park, KU; Seo, SH; Song, J; Yoon, S, 2021) |
| "Before and during treatment of tuberculosis, we assessed iron kinetics, as well as changes in inflammation and iron metabolism indices." | ( Cercamondi, CI; Fenner, L; Hella, J; Mhimibra, F; Moretti, D; Stoffel, NU; Swinkels, DW; Zeder, C; Zimmermann, MB; Zoller, T, 2021) |
| "Here we treated M." | ( Arlehamn, CSL; Barber, DL; Barry Iii, CE; Dorosky, DE; Fleegle, JD; Freeman, GJ; Gomez, F; Kauffman, KD; Lora, NE; Namasivayam, S; Oh, S; Sakai, S; Sette, A; Sher, A; Via, LE, 2021) |
| "Timely treatment with anti-tuberculosis therapy (ATT) and downmodulation of the immune response is critical." | ( Ba, JH; Chen, JN; Chen, JX; Lai, WX; Luo, JM; Shi, XH; Shi, YF; Wang, YH; Wu, BQ; Zhang, Y, 2021) |
| "Outcomes of treatment of tuberculosis patients with regimens including pretomanid have not yet been systematically reviewed." | ( de Jong, BC; Decroo, T; Gils, T; Lynen, L; Van Deun, A, 2022) |
| "Screening and treatment of latent tuberculosis infections (LTBI) are required before starting biologics in patients with immune-mediated inflammatory diseases (IMIDs)." | ( Chung, C; Jo, KW; Kim, YJ; Shim, TS, 2022) |
| "Advancements in the diagnosis and treatment of tuberculosis in children include: use of interferon gamma release assays (IGRAs); molecular-based tests; and shorter courses of treatment." | ( Cameron, LH; Cruz, AT, 2022) |
| "Drug products used for treating tuberculosis are one of the most widely reported medicines to be classified as falsified or substandard in low- and middle-income countries, representing a major hazard to health." | ( Cáceres-Pérez, AR; Fariña, JB; Oliva, A; Santoveña-Estévez, A; Suárez-González, J, 2022) |
| "Delay in diagnosis and treatment enhances tuberculosis (TB) transmission and mortality." | ( Balasubramnian, A; Francis, PT; Lalu, JS; Leelamoni, K; Rakesh, PS, 2022) |
| "Delay in diagnosis and treatment enhances tuberculosis (TB) transmission and mortality." | ( Balasubramnian, A; Francis, PT; Lalu, JS; Leelamoni, K; Rakesh, PS, 2022) |
| "Delay in diagnosis and treatment enhances tuberculosis (TB) transmission and mortality." | ( Balasubramnian, A; Francis, PT; Lalu, JS; Leelamoni, K; Rakesh, PS, 2022) |
| "The duration of the standard treatment for tuberculosis can be shortened to four months but this treatment regimen is also based on rifapentine, in addition to isoniazid, pyrazinamide, and moxifloxacin." | ( Brehm, TT; Friesen, I; Heyckendorf, J; Kalsdorf, B; Kandulla, J; Köhler, N; Kuhns, M; Lange, C; Martensen, J; Schmiedel, S; Terhalle, E, 2023) |
| "Additionally, treating tuberculosis with antibiotics also poses a serious risk of hepatotoxicity in the patient's body." | ( Ahmad, W; Alharbi, JN; Alomary, MN; Alyahya, SA; Ansari, MA; Ansari, SMA; Ather, H; Hani, U; Imran, MA; Islam, N; Jamous, YF; Shoaib, S; Wahab, S, 2023) |
| "New drugs to treat tuberculosis which target intractable bacterial populations are required to develop shorter and more effective treatment regimens." | ( Ahmed, S; Chowdhury, S; Gomez, J; Hung, DT; Parish, T, 2023) |
| "Directly observed treatment (DOT) for tuberculosis (TB) is recommended by the World Health Organization." | ( Camara, LM; Cherif, GF; de Jong, BC; Decroo, T; Delamou, A; Gils, T; Hassane-Harouna, S; Ortuño-Gutiérrez, N; Rigouts, L, 2023) |